WO2015133483A1 - グリコシルヘスペレチンとその製造方法並びに用途 - Google Patents
グリコシルヘスペレチンとその製造方法並びに用途 Download PDFInfo
- Publication number
- WO2015133483A1 WO2015133483A1 PCT/JP2015/056230 JP2015056230W WO2015133483A1 WO 2015133483 A1 WO2015133483 A1 WO 2015133483A1 JP 2015056230 W JP2015056230 W JP 2015056230W WO 2015133483 A1 WO2015133483 A1 WO 2015133483A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glycosyl hesperetin
- glycosyl
- hesperidin
- hesperetin
- product
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 58
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 47
- 229940108690 glucosyl hesperidin Drugs 0.000 title 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims abstract description 471
- 235000010209 hesperetin Nutrition 0.000 claims abstract description 328
- -1 glucosyl hesperetin Chemical compound 0.000 claims abstract description 323
- 229960001587 hesperetin Drugs 0.000 claims abstract description 321
- AIONOLUJZLIMTK-UHFFFAOYSA-N hesperetin Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 claims abstract description 321
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 claims abstract description 321
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 claims abstract description 118
- 235000019640 taste Nutrition 0.000 claims abstract description 117
- 239000007787 solid Substances 0.000 claims abstract description 43
- 239000000047 product Substances 0.000 claims description 231
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims description 151
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 150
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims description 150
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims description 150
- 229940025878 hesperidin Drugs 0.000 claims description 150
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims description 150
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 111
- 238000004040 coloring Methods 0.000 claims description 69
- 239000000243 solution Substances 0.000 claims description 68
- 239000003638 chemical reducing agent Substances 0.000 claims description 65
- 239000000126 substance Substances 0.000 claims description 60
- 239000003814 drug Substances 0.000 claims description 55
- 238000006911 enzymatic reaction Methods 0.000 claims description 47
- 235000013305 food Nutrition 0.000 claims description 42
- IMMBLRJLSYJQIZ-UNQGIHKMSA-N (2S)-7-[3,4-dihydroxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one Chemical compound COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(OC3OC(COC4OC(C)C(O)C(O)C4O)C(OC4OC(CO)C(O)C(O)C4O)C(O)C3O)cc2O1 IMMBLRJLSYJQIZ-UNQGIHKMSA-N 0.000 claims description 41
- 239000002994 raw material Substances 0.000 claims description 41
- 239000002537 cosmetic Substances 0.000 claims description 39
- 239000000463 material Substances 0.000 claims description 36
- 239000007864 aqueous solution Substances 0.000 claims description 35
- 108700023372 Glycosyltransferases Proteins 0.000 claims description 27
- 229920002472 Starch Polymers 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 25
- 239000008107 starch Substances 0.000 claims description 25
- 235000019698 starch Nutrition 0.000 claims description 25
- 102000051366 Glycosyltransferases Human genes 0.000 claims description 24
- 239000004033 plastic Substances 0.000 claims description 23
- 229920003023 plastic Polymers 0.000 claims description 23
- 229940079593 drug Drugs 0.000 claims description 21
- 238000010438 heat treatment Methods 0.000 claims description 21
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 20
- 239000011591 potassium Substances 0.000 claims description 20
- 229910052700 potassium Inorganic materials 0.000 claims description 20
- 239000011777 magnesium Substances 0.000 claims description 19
- 229910052749 magnesium Inorganic materials 0.000 claims description 19
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 18
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 17
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 17
- 235000013361 beverage Nutrition 0.000 claims description 17
- 239000011575 calcium Substances 0.000 claims description 17
- 229910052791 calcium Inorganic materials 0.000 claims description 17
- 239000011734 sodium Substances 0.000 claims description 17
- 229910052708 sodium Inorganic materials 0.000 claims description 17
- 238000002835 absorbance Methods 0.000 claims description 9
- 239000007857 degradation product Substances 0.000 claims description 9
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 8
- 102100022624 Glucoamylase Human genes 0.000 claims description 8
- 108010044879 alpha-L-rhamnosidase Proteins 0.000 claims description 8
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 claims description 7
- 239000007858 starting material Substances 0.000 claims description 6
- 108090000637 alpha-Amylases Proteins 0.000 claims description 5
- UAJRSHJHFRVGMG-UHFFFAOYSA-N 1-ethenyl-4-methoxybenzene Chemical compound COC1=CC=C(C=C)C=C1 UAJRSHJHFRVGMG-UHFFFAOYSA-N 0.000 claims description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical group OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 4
- 102000004139 alpha-Amylases Human genes 0.000 claims description 4
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 4
- 229940024171 alpha-amylase Drugs 0.000 claims description 4
- 238000009616 inductively coupled plasma Methods 0.000 claims description 3
- CKMNPXWFAZLBNK-QOFYEYOWSA-N OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O Chemical compound OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O CKMNPXWFAZLBNK-QOFYEYOWSA-N 0.000 claims description 2
- 238000004993 emission spectroscopy Methods 0.000 claims description 2
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 90
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- 238000011156 evaluation Methods 0.000 description 30
- 239000003795 chemical substances by application Substances 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 201000010099 disease Diseases 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 21
- 229920001353 Dextrin Polymers 0.000 description 19
- 239000004375 Dextrin Substances 0.000 description 19
- 239000003463 adsorbent Substances 0.000 description 19
- 235000019425 dextrin Nutrition 0.000 description 19
- 102000004190 Enzymes Human genes 0.000 description 18
- 108090000790 Enzymes Proteins 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 18
- 229940091250 magnesium supplement Drugs 0.000 description 18
- 230000008901 benefit Effects 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 16
- 206010013911 Dysgeusia Diseases 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 15
- 239000007788 liquid Substances 0.000 description 15
- 239000006071 cream Substances 0.000 description 14
- 238000000746 purification Methods 0.000 description 13
- 239000012086 standard solution Substances 0.000 description 13
- 239000006210 lotion Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- 230000001953 sensory effect Effects 0.000 description 12
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 12
- 229940124597 therapeutic agent Drugs 0.000 description 12
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 11
- 235000010262 sodium metabisulphite Nutrition 0.000 description 11
- 239000003381 stabilizer Substances 0.000 description 11
- 239000003963 antioxidant agent Substances 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 230000003449 preventive effect Effects 0.000 description 10
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 10
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 235000019658 bitter taste Nutrition 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 229920001429 chelating resin Polymers 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 239000006072 paste Substances 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 235000019606 astringent taste Nutrition 0.000 description 7
- 150000001720 carbohydrates Chemical group 0.000 description 7
- 125000003147 glycosyl group Chemical group 0.000 description 7
- 210000004209 hair Anatomy 0.000 description 7
- 150000008040 ionic compounds Chemical class 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 239000000516 sunscreening agent Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 238000011088 calibration curve Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 230000000475 sunscreen effect Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000003796 beauty Effects 0.000 description 5
- 235000020971 citrus fruits Nutrition 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical group C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 235000010265 sodium sulphite Nutrition 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- 229920002245 Dextrose equivalent Polymers 0.000 description 4
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000008103 glucose Chemical group 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 108010030923 hesperidinase Proteins 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 238000000691 measurement method Methods 0.000 description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 4
- 235000019345 sodium thiosulphate Nutrition 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 240000007154 Coffea arabica Species 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical group C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000235070 Saccharomyces Species 0.000 description 3
- 108010019077 beta-Amylase Proteins 0.000 description 3
- 235000016213 coffee Nutrition 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 3
- 229960004352 diosmin Drugs 0.000 description 3
- 231100000676 disease causative agent Toxicity 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 3
- 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 3
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 3
- 235000010263 potassium metabisulphite Nutrition 0.000 description 3
- 230000000069 prophylactic effect Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- RYYXDZDBXNUPOG-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(N)CCC2=C1SC(N)=N2 RYYXDZDBXNUPOG-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- 241000555281 Brevibacillus Species 0.000 description 2
- 241000186146 Brevibacterium Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000626621 Geobacillus Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000205160 Pyrococcus Species 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000003788 bath preparation Substances 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 2
- 125000000953 rutinose group Chemical group 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 1
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 244000175448 Citrus madurensis Species 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 235000017317 Fortunella Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 241000179039 Paenibacillus Species 0.000 description 1
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000186339 Thermoanaerobacter Species 0.000 description 1
- 241000205188 Thermococcus Species 0.000 description 1
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- 125000003691 alpha-D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 229940127226 anticholesterol agent Drugs 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- XQKKWWCELHKGKB-UHFFFAOYSA-L calcium acetate monohydrate Chemical compound O.[Ca+2].CC([O-])=O.CC([O-])=O XQKKWWCELHKGKB-UHFFFAOYSA-L 0.000 description 1
- 229940067460 calcium acetate monohydrate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- GBAOBIBJACZTNA-UHFFFAOYSA-L calcium sulfite Chemical compound [Ca+2].[O-]S([O-])=O GBAOBIBJACZTNA-UHFFFAOYSA-L 0.000 description 1
- 235000010261 calcium sulphite Nutrition 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- PGZIKUPSQINGKT-UHFFFAOYSA-N dialuminum;dioxido(oxo)silane Chemical compound [Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O PGZIKUPSQINGKT-UHFFFAOYSA-N 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- FGRVOLIFQGXPCT-UHFFFAOYSA-L dipotassium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [K+].[K+].[O-]S([O-])(=O)=S FGRVOLIFQGXPCT-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000035611 feeding Effects 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013569 fruit product Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 150000002483 hydrogen compounds Chemical class 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLSMFKSTNGKWQX-UHFFFAOYSA-N hydroxyacetone Chemical compound CC(=O)CO XLSMFKSTNGKWQX-UHFFFAOYSA-N 0.000 description 1
- 150000002443 hydroxylamines Chemical class 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- OVGXLJDWSLQDRT-CEOVSRFSSA-L magnesium;(2s)-2-hydroxypropanoate Chemical compound [Mg+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O OVGXLJDWSLQDRT-CEOVSRFSSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229940099427 potassium bisulfite Drugs 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000002098 selective ion monitoring Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 229940056729 sodium sulfate anhydrous Drugs 0.000 description 1
- NGSFWBMYFKHRBD-DKWTVANSSA-M sodium;(2s)-2-hydroxypropanoate Chemical compound [Na+].C[C@H](O)C([O-])=O NGSFWBMYFKHRBD-DKWTVANSSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 238000005918 transglycosylation reaction Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/205—Heterocyclic compounds
- A23L27/2052—Heterocyclic compounds having oxygen or sulfur as the only hetero atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/84—Flavour masking or reducing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
Definitions
- the present invention relates to a novel glycosyl hesperetin, and more particularly, to a glycosyl hesperetin having a significantly reduced miscellaneous taste, a method for producing the same, and a use thereof.
- the glycosyl hesperetin referred to in the present specification means all compounds in which a saccharide is bound to hesperetin (hereinafter referred to as “compound having a hesperetin skeleton”), and specific examples thereof include: Hesperidin, 7-O- ⁇ -glucosyl hesperetin having a structure in which the rhamnose group constituting hesperidin's rutinose is removed, and saccharides (eg, saccharides such as D-glucose, D-fructose, or D-galactose) in hesperidin, etc. Examples include ⁇ -glycosyl hesperidin that is ⁇ -linked in a mo
- vitamin P is involved in the physiological action of vitamin C in vivo, such as the hydroxylation of proline and lysine necessary for the synthesis of collagen, which is the main component of biological connective tissue.
- vitamin C in vivo
- reducing C of Fe +++ participate in redox reactions such as the Fe ++, furthermore, known to be involved in immune potentiation by leukocytosis, health maintenance of a living body, to promote important It is known to play a role.
- Hesperidin known as vitamin P is a compound represented by the following chemical formula 1 having a structure in which rutinose composed of rhamnose and glucose is bound to hesperetin, and is a kind of flavonoid contained in citrus pericarp and the like, and is a capillary blood vessel. It has been known for a long time as vitamin P having physiological functions such as enhancement of blood pressure, prevention of bleeding, and regulation of blood pressure, and is widely used in foods and drinks, cosmetics, pharmaceuticals and the like.
- hesperidin is not limited to vitamin P fortifier as a nutrient, but due to its chemical structure and physiological function, it can be used alone or in combination with other vitamins, for example, antioxidants, stabilizers, quality improvement, etc.
- vitamins for example, antioxidants, stabilizers, quality improvement, etc.
- agents for example, antioxidants, stabilizers, quality improvement, etc.
- prophylactic and therapeutic agents for diseases such as viral diseases, bacterial diseases, cardiovascular diseases, malignant tumors sensitive to hesperidin, ie, hesperidin sensitive diseases
- the range of applications is extremely wide, ranging from pharmaceuticals to cosmetics such as skin beautifiers, fairing agents, anti-aging agents, and the like as stabilizers, antioxidants, ultraviolet absorbers, melanin production inhibitors and the like.
- hesperidin is hardly soluble in water, and only 1 g (about 0.002 w / v%) is dissolved in 50 L of water at room temperature, which is extremely difficult to use.
- Patent Document 1 discloses that a glycosyltransferase is allowed to act on a solution containing hesperidin and a partially decomposed starch so as to have high water solubility, no toxicity, and in vivo.
- ⁇ -glycosyl hesperidin which is easily hydrolyzed and exhibits the original physiological function of hesperidin and a method for producing the same are disclosed.
- ⁇ -Glucosyl hesperidin also known as enzyme-treated hesperidin, transglycosylated hesperidin, water-soluble hesperidin, or transglycosylated vitamin P
- ⁇ -glycosyl hesperidin is ⁇ -bonded to glucose in the rutinose structure of hesperidin.
- sugar transfer hesperidin (trade name “Hayashibara Hesperidin (registered trademark) S”, sold by Hayashibara Co., Ltd.) is commercially available.
- ⁇ -L-rhamnosidase (EC 3.2.1.40) is allowed to act on a solution containing hesperidin together with a high concentration of ⁇ -glucosyl hesperidin to convert hesperidin to 7-O- ⁇ .
- -A method for producing a high ⁇ -glucosyl hesperidin content which is converted to glucosyl hesperetin, reduces the residual hesperidin content, and has improved water solubility is disclosed.
- glycosyl hesperetin-containing product containing so-called glycosyl hesperetin such as hesperidin, ⁇ -glucosyl hesperidin, 7-O- ⁇ -glucosyl hesperetin (hereinafter sometimes simply referred to as “conventional product”) is unique. It has a bitter taste (including astringency, gummy, astringent taste) and an unfavorable aftertaste, that is, a miscellaneous taste. Conventionally, as a means for improving this defect, for example, Patent Document 3 discloses glycosyl hesperetin. A method of adding malic acid to a beverage containing ⁇ -glycosyl hesperidin (also known as water-soluble hesperidin) is disclosed.
- the present invention has been made to solve the above-mentioned drawbacks, and it is an object of the present invention to provide glycosyl hesperetin having a significantly reduced miscellaneous taste as compared with conventional products, a method for producing the same, and use.
- the inventors of the present invention paid attention to the miscellaneous taste that was a defect of the conventional product, and made intensive research efforts to solve this defect. That is, in the process of the present invention, the miscellaneous taste of the conventional product is a substance that causes miscellaneous taste in the raw material for production (hereinafter sometimes simply referred to as “causative substance of miscellaneous taste”). It was hypothesized that it was originally contained or that a causative substance was produced in the manufacturing process.
- the present inventors found that the miscellaneous taste was significantly higher than that of the conventional product when a reducing agent coexists in the production process of glycosyl hesperetin. It was newly found that reduced glycosyl hesperetin can be obtained. Furthermore, the present inventors have newly found that such glycosyl hesperetin has significantly reduced coloring and odor as compared with conventional products. Furthermore, the present inventors compared the properties of the glycosyl hesperetin thus obtained in detail with those of the conventional product. (A) Both of them are based on glycosyl hesperetin.
- the present invention in which miscellaneous taste is significantly reduced.
- the glycosyl hesperetin has a significantly lower furfural content compared to the conventional product.
- a product with a significantly lower furfural content than the conventional product is a glycosyl hesperetin with a significantly reduced miscellaneous taste.
- the present inventors have newly found that the furfural content can be an index for obtaining glycosyl hesperetin with a significantly reduced miscellaneous taste.
- the present inventors focused on the furfural contained in the glycosyl hesperetin as an index for obtaining a glycosyl hesperetin with a significantly reduced miscellaneous taste, which was a drawback of the conventional product, As a means for obtaining glycosyl hesperetin having a significantly reduced furfural content, a reducing agent is used in the production process to obtain glycosyl hesperetin having a significantly reduced miscellaneous taste compared to conventional products, and a method for producing the same. In addition, the application has been established and the present invention has been completed.
- the present invention solves the above problems by providing glycosyl hesperetin substantially free of furfural.
- substantially free of furfural means glycosyl hesperetin having a significantly lower level of furfural content than conventional products.
- GC / MS analysis method an analysis method using a gas chromatograph mass (GC / MS) analyzer shown in “(1) Furfural content” in Experiment 1 described later (hereinafter abbreviated as “GC / MS analysis method”).
- glycosyl hesperetins of the present invention those in which the furfural content is reduced to below the detection limit of the GC / MS analysis method are significantly reduced in miscellaneous taste and markedly colored compared to the conventional product. It is a reduced, very high quality glycosyl hesperetin.
- glycosyl hesperetin of the present invention apart from the use of the glycosyl hesperetin of the present invention in the fields of medicine, precision instruments, etc., it is not always necessary to use the highest purity glycosyl hesperetin, foods and drinks, luxury products, cosmetics, industrial raw materials In addition, it is not always necessary to use the highest purity glycosyl hesperetin when used in fields such as materials, feed, feed, clothing, sundries (including daily necessities), or plastic products. There is not necessarily a need to be reduced to the following levels or a need to be free of furfural.
- the glycosyl hesperetin of the present invention does not need to contain substantially furfural, and as long as the intended purpose of the present invention can be achieved, the amount of furfural significantly lower than the conventional product or below the detection limit. You may contain.
- the present invention also includes (a) a step of preparing an aqueous solution containing hesperidin and a partially decomposed starch, and (a) a step of producing a glycosyl hesperetin containing ⁇ -glucosyl hesperidin by allowing a glycosyltransferase to act on the obtained aqueous solution.
- the present invention relates to foods and drinks, luxury products, cosmetics, pharmaceuticals, quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, sundries (daily necessities) comprising the glycosyl hesperetin of the present invention.
- the above-mentioned problems are solved by providing a plastic product.
- the present invention solves the above-mentioned problems by providing a method for reducing the miscellaneous taste of a glycosyl hesperetin-containing product, which comprises contacting the glycosyl hesperetin-containing product with a reducing agent.
- glycosyl hesperetin according to the present invention has an excellent feature that the miscellaneous taste is significantly reduced, unlike the conventional product. Furthermore, according to the method for producing glycosyl hesperetin of the present invention or the method for reducing the miscellaneous taste of a glycosyl hesperetin-containing product of the present invention, glycosyl hesperetin having a significantly reduced miscellaneous taste compared to the conventional product is industrially produced in a large amount and stable. In addition, it is possible to provide excellent benefits that can be provided easily and inexpensively in a high yield.
- the conventional product can be suitably used for articles that are difficult or troublesome because of the miscellaneous taste, or because of miscellaneous taste and coloring, and further due to odor.
- the glycosyl hesperetin of the present invention is produced through a heating process because the miscellaneous taste is significantly reduced and the coloring and odor are significantly reduced even when heated, compared to the conventional product. Even if it is an article to be manufactured, it is possible to provide an excellent benefit that a higher quality product can be provided.
- the glycosyl hesperetin according to the present invention is a novel glycosyl hesperetin having a common taste that is significantly reduced as compared with the conventional product, although it is similar to the conventional product in that it is mainly composed of glycosyl hesperetin.
- the glycosyl hesperetin referred to in the present invention is a compound having a hesperetin skeleton (1) ⁇ -glycosyl hesperidin (such as ⁇ -glucosyl hesperidin) and (2) one or both of hesperidin and 7-O- ⁇ -glucosyl hesperetin.
- ⁇ -glycosyl hesperidin such as ⁇ -glucosyl hesperidin
- 7-O- ⁇ -glucosyl hesperetin is a glycosyl hesperetin mixture, and is considered to be derived from the raw material of the production or produced as a secondary product in the production process.
- Nariltin, diosmine, neoponcillin It contains flavonoids such as glucosylnariltin and (4) trace components such as salts.
- the total proportion (mass%) of the components (1) and (2) in the glycosyl hesperetin of the present invention (hereinafter, simply referred to as “glycosyl hesperetin content” unless otherwise specified) is usually per dry solid.
- the highest purity glycosyl hesperetin is not necessarily required, that is, even if it is a relatively low purity glycosyl hesperetin, there is a particular problem.
- fields such as foods and beverages, luxury goods, cosmetics, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), or plastic products, take into account their final form.
- the purity of the glycosyl hesperetin of the present invention that is, the upper limit of the content of glycosyl hesperetin per dry solid can be usually provided in a relatively large amount, inexpensively and easily industrially. 99%, 98% to provide cheaper, and 97% or less to provide even cheaper It may be.
- the glycosyl hesperetin content per dry solid of the glycosyl hesperetin of the present invention is low, it is inevitably used in a large amount as compared with the high content, resulting in complicated operation and poor handling. Therefore, the lower limit of the glycosyl hesperetin content is usually 90% or more, preferably 93% or more, more preferably 95% or more, and more preferably 97% by mass or more.
- the glycosyl hesperetin of the present invention when the glycosyl hesperetin is ⁇ -glycosyl hesperidin such as ⁇ -glucosyl hesperidin, the ⁇ -glycosyl hesperidin content per dry solid is 50% or more and less than 100%. It can be illustrated.
- the upper limit of the ⁇ -glucosyl hesperidin content of the glycosyl hesperetin of the present invention is usually set when the glycosyl hesperetin of the present invention is provided at a lower cost. However, it may be 90% or less, 85% or less for cheaper and 80% or less for cheaper, which can be provided in a relatively large amount, inexpensively and easily industrially.
- the lower limit of the ⁇ -glucosyl hesperidin content is usually preferably 60% or more, 65% or more, or 70% or more for the same reason as the glycosyl hesperetin content.
- a preferred embodiment of the glycosyl hesperetin of the present invention is one containing 60 to 90% ⁇ -glucosyl hesperidin per dry solid.
- glycosyl hesperetin content of the glycosyl hesperetin of the present invention described above can be determined using a general-purpose measuring instrument in this field. For example, a part of the glycosyl hesperetin of the present invention is sampled, diluted or dissolved in purified water, for example, 0.1 w / w%, and filtered through a commercially available 0.45 ⁇ m membrane filter.
- the sample was subjected to high performance liquid chromatography (hereinafter referred to as “HPLC”) analysis under the following conditions, using the reagent hesperidin (sold by Wako Pure Chemical Industries, Ltd.) as a standard substance, and the area of each peak appearing in the chromatogram at UV 280 nm , Based on the molecular weight of each glycosyl hesperetin such as hesperidin, ⁇ -glycosyl hesperidin ( ⁇ -glucosyl hesperidin, etc.) and 7-O- ⁇ -glucosyl hesperetin corresponding to each peak.
- the outline of quantification of glycosyl hesperetin is as follows.
- Hesperidin content Analyzed by HPLC, and calculated based on the ratio of the peak area to the peak area of the reagent hesperidin (sold by Wako Pure Chemical Industries, Ltd.) as a standard substance with a predetermined concentration.
- ⁇ -Glucosyl hesperidin content Analyzed by HPLC, the ratio of the peak area to the peak area of the reagent hesperidin (sales of Wako Pure Chemical Industries, Ltd.) as a standard substance of a predetermined concentration, and ⁇ -glucosyl hesperidin Calculated based on the molecular weight ratio of hesperidin.
- glycosyl hesperetin content Analyzed by HPLC, the ratio of the peak area to the peak area of the reagent hesperidin (sold by Wako Pure Chemical Industries, Ltd.) as a standard substance of a predetermined concentration, and other glycosyl hesperetin Calculated based on the molecular weight ratio with hesperidin.
- the glycosyl hesperetin content per dry solid in the glycosyl hesperetin of the present invention is the total glycosyl hesperetin determined in the above (1) to (4) with respect to the mass in terms of anhydride of the glycosyl hesperetin of the present invention used as a sample. It means the percentage of content.
- the glycosyl hesperetin of the present invention is a glycosyl hesperetin with a significantly reduced miscellaneous taste as compared with conventional products, and is a glycosyl hesperetin substantially free of furfural obtained by using the furfural content as an index.
- the furfural content in the glycosyl hesperetin of the present invention is an index for obtaining glycosyl hesperetin having a significantly reduced miscellaneous taste, and the present specification uses this furfural content as an index to indicate that the misty taste is significant.
- Discloses a method for producing reduced glycosyl hesperetin Needless to say, the lower the furfural content, the glycosyl hesperetin has a significantly reduced miscellaneous taste.
- 4-vinylanisole also referred to as: A substance that does not substantially contain 4-methoxystyrene (hereinafter abbreviated as “4-VA”) has been found to have a markedly reduced coloring as well as a miscellaneous taste among the glycosyl hesperetins of the present invention. It was.
- 4-VA is a component presumed to be generated due to the raw material for producing the glycosyl hesperetin of the present invention, and its content in the glycosyl hesperetin of the present invention is usually less than 30 ppb per dry solid,
- the VA content generally has a parallel relationship with the furfural content when the furfural content is less than 200 ppb.
- the fact that 4-VA is not substantially contained means that the 4-VA content is significantly lower than that of the conventional product, as in the case of furfural. More specifically, the 4-VA content in the glycosyl hesperetin of the present invention is measured by an analytical method using a GC / MS analyzer shown in “(2) 4-VA content” in Experiment 1 described later.
- ppb preferably less than 15 ppb, more preferably less than 10 ppb, even more preferably less than 5 ppb, even more preferably less than 3 ppb, even more preferably 2 ppb per dry solid. Means less than.
- the glycosyl hesperetin of the present invention has an excellent characteristic that the miscellaneous taste is significantly reduced, which is a drawback of the conventional product. That is, the glycosyl hesperetin of the present invention itself not only has a significantly reduced taste compared to the conventional product, but also has a significantly reduced taste compared to the conventional product even when heated in an aqueous solution. It has excellent characteristics.
- the miscellaneous taste of the glycosyl hesperetin of the present invention can be examined by a sensory test using a panel shown in “Experiment 2: Sensory test” described later.
- the glycosyl hesperetin of the present invention has an excellent feature that the coloring (hereinafter, sometimes referred to as “coloring degree”) is significantly reduced as compared with the conventional product.
- the coloring degree of the glycosyl hesperetin of the present invention is measured by the method shown in “(2) Color tone and coloring degree” of Experiment 1 described later, and the outline thereof is as follows.
- the color tone of the treatment liquid is visually observed, and the spectrophotometer is used to measure the absorbance at a wavelength of 420 nm (OD 420 nm ) and the wavelength at 720 nm.
- Absorbance (OD 720 nm ) is measured, the difference in absorbance at both wavelengths (OD 420 nm -OD 720 nm ) is determined, and the measured value is taken as the coloring degree.
- the difference in absorbance is less than 0.24, preferably 0.20 or less, more preferably 0.17 or less, and even more preferably 0 or more and 0.15 or less.
- the aqueous solution of glycosyl hesperetin is heated in consideration of the disadvantage that the conventional product has a drawback that the degree of coloration is significantly increased by heating. It is set for the purpose of accurately evaluating the degree.
- glycosyl hesperetin of the present invention a 1 w / w% aqueous solution is prepared, heated in a sealed container at 100 ° C. for 30 minutes, cooled, and brought to 20 ° C. with an electric conductivity of less than 10 ⁇ S / cm.
- Glycosyl hesperetin that is preferably less than 8 ⁇ S / cm, more preferably less than 6 ⁇ S / cm, and still more preferably more than 0 ⁇ S / cm and less than 4.5 ⁇ S / cm can be exemplified.
- the electrical conductivity can be measured with a general-purpose electrical conductivity meter.
- the glycosyl hesperetin of the present invention Since the conventional product usually exhibits an electric conductivity of more than 10 ⁇ S / cm, the glycosyl hesperetin of the present invention has a characteristic that the ionic compound content is lower than that of the conventional product. In this measurement method, the reason for heating the aqueous solution of glycosyl hesperetin of the present invention is set in view of the behavior of the coloring degree.
- glycosyl hesperetin of the present invention there can be exemplified those having a low content of calcium, potassium, magnesium, and sodium, which are ionic compounds that influence the electrical conductivity of the glycosyl hesperetin, as compared with conventional products.
- the calcium, potassium, magnesium, and sodium contents in the glycosyl hesperetin of the present invention can be measured by, for example, general-purpose high frequency inductively coupled plasma emission spectrometry in this field.
- the calcium, potassium, magnesium, and sodium contents per dry solid of the glycosyl hesperetin are 1 ppm or less, 0.1 ppm or less, 0.2 ppm or less, respectively, The thing which is 0.4 ppm or less can be illustrated. More preferably, those having calcium, potassium, magnesium, and sodium contents of 0.6 ppm or less, 0.06 ppm or less, 0.1 ppm or less, and 0.3 ppm or less can be exemplified.
- the calcium, potassium, magnesium, and sodium contents are 0 ppm to 0.5 ppm, 0 ppm to 0.05 ppm, 0 ppm to 0.08 ppm, and 0 ppm to 0.2 ppm, respectively. it can.
- the glycosyl hesperetin of the present invention has a reduced electric conductivity and a concentration of metal elements (metal ions) such as calcium, potassium, magnesium, and sodium as compared with conventional products. Alternatively, it is judged that the content of physiologically acceptable ionic compounds such as other ionic components is reduced.
- the production method of the present invention comprises (a) a step of preparing an aqueous solution containing hesperidin and a partially decomposed product of starch, and (b) a glycosyltransferase is allowed to act on the obtained aqueous solution to produce glycosyl hesperetin containing ⁇ -glucosyl hesperidin.
- a method for producing glycosyl hesperetin comprising: (c) collecting the produced glycosyl hesperetin, wherein one or more of the steps (a) to (c) are carried out in the presence of a reducing agent.
- it is a method for producing glycosyl hesperetin by adding a reducing agent to the starting material before one or more of the steps (a) to (c) and / or the resulting product after the step.
- a reducing agent such as sugar transfer reaction
- the reducing agent treatment such as sugar transfer reaction
- the purification method used in the production method will be sequentially described.
- any of the hesperidins used in the production of conventional products can be used, and not only high-purity hesperidin but also relatively low-purity hesperidin-containing plant extracts, juices, or partial purification thereof 1 type or 2 types or more, such as a thing, can be used in combination as appropriate.
- the hesperidin-containing plant include citrus fruits belonging to the genus Citrus mandarin, such as mandarin oranges, oranges, citrus citrus fruits, miscellaneous citrus fruits, tangoles, tanzeros, buntans, kumquats, and daidais.
- the contained site include those fruits, pericarps, seeds, and immature fruits.
- any glycosyltransferase can be used as long as it can transfer to hesperidin to produce ⁇ -glycosyl hesperidin as glycosyl hesperetin when a glycosyltransferase described below is allowed to act.
- Dextrin, cyclodextrin, malto-oligosaccharide and other starch partial decomposition products, and one or more starch partial decomposition products selected from liquefied starch, gelatinized starch and the like are appropriately selected.
- the amount of the partially decomposed starch used in the enzyme reaction described later is usually about 0.1 to about 150 times, preferably about 1 to about 100 times, more preferably, relative to the mass of the raw material hesperidin. Is used in an amount selected from the range of about 2 to about 50 times.
- the sugar derived from the partial starch degradation product is transferred to hesperidin, and ⁇ -glycosyl hesperidin is efficiently produced.
- excess unreacted hesperidin remains in the enzymatic reaction system as much as possible. It is desirable to use an amount of starch partial degradation product.
- the enzyme reaction referred to in the present invention means an enzyme reaction in which ⁇ -glycosyl hesperidin is produced by allowing a glycosyltransferase to act on hesperidin as a production raw material and a partially degraded starch.
- ⁇ -glucosidase As the glycosyltransferase used in the enzymatic reaction, ⁇ -glucosidase (EC 3.2.1.20), cyclomaltodextrin / glucanotransferase (EC 2.4.1.19, hereinafter referred to as “CGTase”). , ⁇ -amylase (EC 3.2.1.1) and the like.
- Examples of ⁇ -glucosidase include enzymes derived from animal and plant tissues such as pig liver and buckwheat seed, or Aspergillus genus such as Mucor genus, Penicillium genus, Aspergillus niger, etc.
- CGTase derived from a fungus culture belonging to the above or a culture obtained by culturing a microorganism such as yeast belonging to the genus Saccharomyces in a nutrient medium includes, for example, the Bacillus genus, Geobacillus genus, Klebsiella genus, Paenibacillus genus, Thermococcus genus, Thermomore Erotic Citrobacter (Thermoanaerobacter) genus Brevibacterium (Brevibacterium) genus Pyrococcus (Pyrococcus) genus Brevibacillus (Brevibacillus) genus, and it can be exemplified those Saccharomyces (Saccharomyces) genus from.
- ⁇ -amylase one or two or more kinds derived from bacteria belonging to the genus Aspergillus such as bacteria belonging to the genus Geobacillus or Aspergillus niger are used in appropriate combination. be able to.
- These glycosyltransferases can be either natural or genetically modified as long as the object of the present invention can be achieved, and if there are commercially available products, they can also be used as appropriate. Moreover, it is not always necessary to purify and use any of the above-mentioned glycosyltransferases. Usually, even a crude enzyme can be used as long as the object of the present invention can be achieved.
- the production rate of ⁇ -glycosyl hesperidin can be increased by adopting a partially degraded starch suitable for the glycosyltransferase.
- malto-oligosaccharides such as maltose, maltotriose, maltotetraose, or dextrose equivalent (DE) from about 10 to about 70 starch partial degradation products, when CGTase is used, From ⁇ -, ⁇ -, or ⁇ -cyclodextrin or starch paste of DE1 or less to a starch partial degradation product of DE about 60, and further, when ⁇ -amylase is used, from starch paste of DE1 or less to DE about 30 A starch partial decomposition product such as dextrin is preferably used.
- DE dextrose equivalent
- hesperidin-containing solution As the hesperidin-containing solution at the time of the enzyme reaction, a solution containing hesperidin as high as possible is desirable.
- hesperidin is suspended or dissolved in a solvent such as water at a high temperature, or pH 7.0 using an alkaline agent.
- the alkaline agent one or two or more strong alkaline aqueous solutions such as sodium hydroxide aqueous solution, potassium hydroxide aqueous solution, sodium carbonate aqueous solution, calcium hydroxide aqueous solution, aqueous ammonia, etc. of about 0.1 to about 1.0 N are used. It can be used as appropriate.
- the concentration of hesperidin when hesperidin is used in the form of a solution using an alkaline agent is usually about 0.005 w / v% or more, preferably about 0.05 to 10 w / v%, more preferably about 0.5 to About 10 w / v%, more preferably about 1 to about 10 w / v%.
- hesperidin when hesperidin is used in a suspended form without using an alkaline agent, hesperidin is suspended in a solvent such as water to form a suspended hesperidin, and the concentration of hesperidin is usually about 0.1 to about 2 w / v%, more preferably about 0.2 to about 2 w / v%, more preferably about 0.3 to about 2 w / v%.
- the temperature and time when glycosyltransferase is allowed to act on hesperidin and starch partial degradation products are the concentrations of hesperidin and starch partial degradation products used in the enzymatic reaction, the type of glycosyltransferase, the optimum temperature, the optimum pH, or the action.
- about 50 to about 100.degree. C. preferably about 60 to about 90.degree. C., more preferably about 70 to about 90.degree. C., and about 5 to about 100 hours.
- it is in the range of about 10 to about 80 hours, more preferably about 20 to about 70 hours.
- the pH and temperature when glycosyltransferase is allowed to act on an alkaline solution containing a high concentration of hesperidin depends on the type of glycosyltransferase, the optimum pH, the optimum temperature, the amount of action, and the concentration of hesperidin. As high as possible at which the glycosyltransferase can act, as high as possible, specifically at a pH of about 7.5 to about 10, preferably a pH of about 8 to about 10, and a pH of about 40 to about 80. ° C, more preferably in the range of about 50 to about 80 ° C. Since hesperidin in the alkaline solution is liable to decompose, it is desirable to keep hesperidin as light-shielded and anaerobic as possible in order to prevent this.
- the pH at which glycosyltransferase acts on suspended hesperidin varies depending on the type of glycosyltransferase, the optimum temperature, the optimum pH, or the amount of action, and the concentration of suspended hesperidin.
- the pH is in the range of about 4 to about 7, preferably about 4.5 to about 6.5.
- hesperidin-rich solution in order to increase the solubility of hesperidin before the enzyme reaction and facilitate the transglycosylation reaction to hesperidin, it is highly compatible with water in a hesperidin-rich solution, particularly in a hesperidin-rich aqueous solution.
- An appropriate amount of an organic solvent such as methanol, ethanol, n-propanol, iso-propanol, n-butanol, acetol, acetone, and other lower alcohols, lower ketones, and the like may be optionally present together.
- the amount of enzyme and reaction time are closely related, and usually from an economic viewpoint, about 5 to about 150 hours, preferably about 10 to about 100 hours, more preferably about 20 to about 80 hours.
- the amount of the enzyme that terminates the enzyme reaction may be appropriately set according to the type of glycosyltransferase using the enzyme amount.
- the enzyme reaction solution containing ⁇ -glycosyl hesperidin and hesperidin obtained after the glycosyltransferase reaction is used as it is or after purification with a porous synthetic adsorption resin, if necessary, and then glucoamylase (EC 3.2.1). .3), or by partial hydrolysis with an amylase such as ⁇ -amylase (EC 3.2.1.2) to reduce the number of ⁇ -D-glucosyl groups of ⁇ -glycosyl hesperidin.
- glucoamylase is allowed to act, a polymer higher than ⁇ -maltosyl hesperidin can be hydrolyzed to produce glucose and to produce and accumulate ⁇ -glucosyl hesperidin.
- ⁇ -amylase when allowed to act, a polymer higher than ⁇ -maltotriosyl hesperidin is hydrolyzed to generate maltose, and a mixture containing ⁇ -glucosyl hesperidin and ⁇ -maltosyl hesperidin is generated. Can be accumulated.
- glucoamylase and ⁇ -L-rhamnosidase have a close relationship between the amount of the enzyme and the enzyme reaction time.
- about 5 to about 150 hours preferably The amount of the enzyme that completes the enzyme reaction in about 10 to about 100 hours, more preferably about 20 to about 80 hours, may be appropriately set according to the type of enzyme used. It is also possible to carry out the reaction repeatedly in batch mode using immobilized ⁇ -L-rhamnosidase, or to perform reaction in a continuous mode without interruption.
- Reducing agent treatment means treatment for significantly reducing the miscellaneous taste of glycosyl hesperetin using a reducing agent, and prepares an aqueous solution containing (a) hesperidin and starch partial degradation products as described below.
- the reducing agent is not particularly limited as long as the intended purpose of the present invention can be achieved, and any of general-purpose inorganic and organic reducing agents can be used in this field.
- any of general-purpose inorganic and organic reducing agents can be used in this field.
- the glycosyl hesperetin of the present invention is mainly premised on application to humans, it is desirable to use a reducing agent that is highly safe and has excellent stability and handleability.
- reducing agent suitably used include, for example, hydroxylamines, hydrazine compounds, chlorine dioxide, hydrogen, hydrogen compounds (hydrogen sulfide, sodium borohydride, lithium aluminum hydride, potassium aluminum hydride, etc.), Sulfur compounds (sulfur dioxide, thiourea dioxide, thiosulfate, sulfite, iron sulfate, sodium persulfate, potassium persulfate, ammonium persulfate, calcium sulfite, etc.), nitrite, tin chloride, iron chloride, potassium iodide, persulfate
- Inorganic reducing agents such as hydrogen oxide, diluted benzoyl peroxide, hydroperoxide, chlorite such as sodium chlorite, phenols, amines, quinones, polyamines, formic acid and its salts, oxalic acid and its Salts, citric acid and its salts, thiourea dioxide, reducing sugars, be
- the former reducing agent provides a high-quality glycosyl hesperetin in which the miscellaneous taste inherent in the conventional product is significantly reduced and the off-flavor is also reduced. Therefore, it can be used more suitably.
- the organic reducing agent is an organic substance, there is a risk that it may itself cause miscellaneous taste and coloration, and the organic reducing agent or a decomposition product thereof is not completely removed in the production process of glycosyl hesperetin of the present invention. This may be because they negatively affect the quality of glycosyl hesperetin.
- sulfites (Also referred to as sulfites) is a reducing agent that can be more suitably used in the present invention because it is excellent in terms of safety, stability, and handleability.
- inorganic reducing agents such as sodium sulfite, potassium sulfite, sodium hydrogen sulfite, sodium hyposulfite, potassium hyposulfite, sodium pyrosulfite, potassium pyrosulfite, sodium metasulfite, potassium metasulfite, sodium metabisulfite, and meta Sulphites such as potassium bisulfite can be most suitably used in the present invention.
- the reducing agent is applied to one step in the production process of glycosyl hesperetin, or the starting material before and / or the resulting product before that step, but two or more steps or before these steps.
- the appropriate amount is appropriately subdivided into the starting material and / or the resulting product, the intended purpose of the present invention can be efficiently achieved with a smaller amount of reducing agent.
- the total amount of the reducing agent added in each of the steps (a) to (c), after the (a) enzyme reaction (when other enzymes other than glycosyltransferase are used, all of them are used). Is usually 0.001% or more, preferably 0.01 to 3%, more preferably 0.01 to 1%, based on the mass of the enzyme reaction solution obtained after More preferably, an amount selected from a range corresponding to 0.01 to 0.5% is used.
- the reducing agent is added before the step (c)
- the remaining reducing agent is usually substantially removed in the purification step, so that the glycosyl hesperetin obtained as a final product is not included in the final product. Virtually not detected.
- the amount of the reducing agent added in all the steps is generally 0.001% or more, preferably 0.01% or more, more preferably, in total, with respect to the mass of the enzyme reaction solution obtained after the enzyme reaction. Is added once or multiple times so as to be in the range of 0.01 to 1%.
- the temperature at the time of addition is usually the temperature employed in the steps (a) to (c), but it can also be set to a temperature higher than that temperature. Specifically, a temperature of room temperature or higher, preferably 50 ° C. or higher, more preferably 70 ° C. or higher, more preferably 80 ° C. or higher, and more preferably 90 to 120 ° C. can be exemplified.
- the enzyme reaction solution thus obtained can be used as it is as the glycosyl hesperetin of the present invention.
- the enzyme reaction solution is appropriately combined with one or more means such as a separation method, a filtration method, a purification method using a porous synthetic resin, a concentration method, a spraying method, a drying method and the like known in the art.
- glycosyl hesperetin in a liquid, solid or powder form can be obtained.
- the porous synthetic resin means a synthetic resin such as a porous, wide adsorption surface area and nonionic styrene-divinylbenzene polymer, phenol-formalin resin, acrylate resin, methacrylate resin, for example.
- Amberlite XAD-1 Amberlite XAD-2, Amberlite XAD-4, Amberlite XAD-7, Amberlite XAD-8, Amberlite XAD-11, And resins such as Amberlite XAD-12; trade names manufactured by Mitsubishi Chemical Corporation: Diaion HP-10, Diaion HP-20, Diaion HP-30, Diaion HP-40, Diaion HP-50, Diamond Ion HP-2MG, Sepa beads SP70, Sepa beads SP 07, Sepabeads SP700, resins such as Sepabeads SP800; and IMACTI Ltd. trade name: Imakuti Syn-42, can be exemplified resins such Imakuti Syn-44, and Imakuti Syn-46.
- glycosyl hesperetin is adsorbed on the porous synthetic adsorbent, while remaining starch partially decomposes. Substances and water-soluble saccharides flow out of the column without being adsorbed.
- the glycosyl hesperetins hesperidin, 7-O- ⁇ -glucosyl hesperetin, and ⁇ -glycosyl hesperidin usually behave together and cannot be separated individually by the porous synthetic adsorbent.
- glycosyl hesperetin-containing eluate thus obtained is distilled to distill off the organic solvent and then concentrated to a desired concentration to obtain the glycosyl hesperetin of the present invention having a reduced hesperidin content.
- the elution operation of glycosyl hesperetin with the organic solvent also serves as a regeneration operation of the porous synthetic adsorbent, which has the advantage of enabling the porous synthetic adsorbent to be used repeatedly.
- liquid glycosyl hesperetin of the present invention having an increased content of glycosyl hesperetin can be produced by combining purification methods such as desalting.
- liquid glycosyl hesperetin is optionally dried and powdered by a known drying method to obtain powdered glycosyl hesperetin.
- glycosyl hesperetin can be produced in which the characteristic miscellaneous taste that has been a drawback of conventional products is effectively reduced significantly.
- the present inventors have confirmed that the miscellaneous taste peculiar to the conventional product that is not treated with the reducing agent is not substantially changed only by applying the purification method. That is, for example, the purification method using the porous synthetic adsorbent, which is widely used in the manufacturing process of conventional products, simultaneously removes not only starch partially decomposed products and water-soluble saccharides but also contaminants such as water-soluble salts. Although it has an advantage that can be achieved, it is difficult to significantly reduce the taste unique to the conventional product, no matter how the purification method is used.
- glycosyl hesperetin The possible reason for the miscellaneous taste contained in glycosyl hesperetin is that the adsorption / desorption behavior to the porous synthetic adsorbent is the same as that of glycosyl hesperetin and cannot be separated from glycosyl hesperetin. Conceivable.
- the glycosyl hesperetin of the present invention has a significantly reduced miscellaneous taste, a low electrical conductivity, and a reduced content of ionic compounds involved in the electrical conductivity as compared with conventional products.
- the ionic compound include nariltin, diosmine, neoponcillin, which is originally contained in hesperidin as a raw material, or a compound such as glucosylnariltin and glucosylneoponcillin, which are enzyme reaction products, and their degradation.
- a compound closely related to the degradation product thereof, and further, furfural as an index in the present invention which is considered to be derived from a production raw material of glycosyl hesperetin or produced as a secondary product in the production process.
- furfuryl alcohol and furfurals such as hydroxymethylfurfural and salts thereof
- compounds that liberate metal cations such as calcium, potassium, magnesium, and sodium in a solution state.
- components such as nariltin, diosmin, neoponcillin, glucosylnariltin, glucosylneoponcillin are usually contained in the glycosyl hesperetin of the present invention in a trace amount.
- the glycosyl hesperetin of the present invention in which the furfural content is significantly reduced is a high-quality glycosyl hesperetin in which the miscellaneous taste is significantly reduced as compared with the conventional product.
- glycosyl hesperetin of the present invention yields glycosyl hesperetin with a significantly reduced miscellaneous taste is not clear, but is estimated as follows.
- glycosyl hesperetin of the present invention When the glycosyl hesperetin of the present invention is produced, there are substances that cause miscellaneous tastes derived from the raw materials for production, and a reducing agent acts on them, and the causative substances are masked, decomposed or modified, and miscellaneous. A glycosyl hesperetin with a significantly reduced taste is obtained.
- the reducing agent reduces or inhibits the generation of the causative agent of the taste, or masks, decomposes or modifies the causative agent of the produced taste, A glycosyl hesperetin with significantly reduced is obtained.
- the causative agent of the taste shown in the above (1) and (2) is modified by a reducing agent, and is easily separated from glycosyl hesperetin in a purification step using a porous synthetic adsorbent and the like. A significantly reduced glycosyl hesperetin is obtained.
- the method for reducing the miscellaneous taste of a glycosyl hesperetin-containing material of the present invention is a method for reducing the misty taste of a glycosyl hesperetin-containing material by bringing the glycosyl hesperetin-containing material into contact with a reducing agent.
- the glycosyl hesperetin containing material said by the miscellaneous taste reduction method of the glycosyl hesperetin of this invention means the glycosyl hesperetin containing whole containing glycosyl hesperetin as a main component.
- coloring of the glycosyl hesperetin-containing product can be effectively and significantly reduced.
- the contact between the glycosyl hesperetin-containing product and the reducing agent is preferably carried out in a solution state or a suspended state using an appropriate solvent such as water, rather than in a solid state.
- Examples of the glycosyl hesperetin to be brought into contact with the reducing agent include glycosyl hesperetin containing one or more selected from hesperidin, ⁇ -glycosyl hesperidin, and 7-O- ⁇ -glucosyl hesperetin.
- glycosyl hesperetin-containing material usually 70% or more and less than 100%, more preferably 80% or more and less than 100%, and more preferably 90% or more and less than 100% of the glycosyl hesperetin per dry solid. Glycosyl hesperetin can be exemplified.
- the reducing agent used in the method for reducing the miscellaneous taste of a glycosyl hesperetin-containing material of the present invention can be the same as that used in the method for producing glycosyl hesperetin of the present invention.
- the amount of the reducing agent used is usually 0.00001% or more, preferably 0.0001 to 0.5%, more preferably 0.001 to 0.4 per dry solid of glycosyl hesperetin. %, And even more preferably, in the range of 0.001 to 0.3%, mixing them uniformly, and bringing the glycosyl hesperetin and the reducing agent into contact with each other significantly improves the taste unique to the conventional product. Can be reduced.
- glycosyl hesperetin of the present invention thus obtained can be provided in various forms such as liquid, paste, solid, granule, and powder.
- the glycosyl hesperetin obtained by the method for producing glycosyl hesperetin of the present invention and the method for reducing the miscellaneous taste of a glycosyl hesperetin-containing product itself has significantly reduced miscellaneous taste, remarkably reduced coloring, and also significant odor.
- the step of containing the glycosyl hesperetin or the inclusion thereof is also possible.
- the miscellaneous taste is significantly reduced compared to the case of using the conventional product.
- Rutotomoni colored, more excellent characteristic that odor is significantly reduced is exerted. Therefore, the glycosyl hesperetin of the present invention is well harmonized with various substances having taste such as acidity, salt to taste, astringency, umami, bitterness, etc., and has high acid resistance and heat resistance.
- Including all food and drink including supplementary foods for example, seasonings, Japanese confectionery, Western confectionery, ice confectionery, beverages (green tea, tea, herbal tea and other tea beverages, fruit juice beverages, soft drinks, coffee, cocoa, drinks, etc.)
- supplementary foods for example, seasonings, Japanese confectionery, Western confectionery, ice confectionery, beverages (green tea, tea, herbal tea and other tea beverages, fruit juice beverages, soft drinks, coffee, cocoa, drinks, etc.)
- alcohols Japanese sake, Western liquor, etc.
- spreads, pastes, pickles, canned bottles, processed meat products, processed fish / fishery products, processed milk / egg products, processed vegetables products, processed fruit products, processed cereal products Can be used.
- it can be advantageously implemented by blending feeds and feeds for domestic animals such as livestock, poultry, bees, sharks, and fish for the purpose of improving vitamin P fortification and palatability.
- glycosyl hesperetin of the present invention can be used as a so-called beauty food, which has been attracting attention recently, as well as in various beauty foods and foods.
- glycosyl hesperetin of the present invention is in the form of lotion, cream, emulsion, gel, powder, paste, block, soap, cosmetic soap, herbal soap, skin wash powder, face wash cream, face wash foam, facial rinse, body shampoo, Cleansing cosmetics such as body rinses, shampoos, rinses, hair washing powders; set lotions, hair blows, tics, hair creams, pomades, hair sprays, hair liquids, hair tonics, hair lotions, hair nourishing agents, hair dyes, scalp treatments, etc.
- Hair cosmetics lotion, vanishing cream, emollient cream, emollient lotion, cosmetics for packs (jelly peel-off type, jelly-type wipe, paste-type rinse, powder, etc.), cleansing cream, cold cream Basic cosmetics such as cream, hand cream, hand lotion, emulsion, moisturizer, after shaving lotion, shaving lotion, pre-shave lotion, after shaving cream, after shaving foam, pre-shave cream, cosmetic oil, baby oil; foundation (liquid, cream Talcum powder, baby powder, body powder, perfume powder, makeup base, funny (cream, paste, liquid, solid, powder, etc.), eye shadow, eye cream, mascara, eyebrow, Makeup cosmetics such as eyelash cosmetics, blusher, cheek lotion; perfume, fragrance perfume, powdered perfume, eau de cologne, perfume cologne, eau de toilette, etc .; sun cream, suntan lotion Sunscreen or sunscreen cosmetics such as sunscreen oil, sunscreen cream, sunscreen lotion, sunscreen oil; nail cosmetics such as nail polish, pedicure, nail color, nail lacquer, enamel remover,
- the glycosyl hesperetin of the present invention includes various solids, pastes, such as tobacco, troches, liver oil drops, complex vitamins, mouth fresheners, mouth pills, mouthwashes, tube feedings, oral medicines, injections, It can also be advantageously carried out by appropriately blending and using it in liquid luxury products, sensitive disease agents such as prophylactic / therapeutic agents for sensitive diseases.
- the glycosyl hesperetin of the present invention can also be suitably applied to chemical products, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), or plastic products.
- the glycosyl hesperetin of the present invention is usually about 0.0001% or more, preferably about 0.001 to about 50%, more preferably about 0.001%, based on the total mass of the various compositions or articles. It is used in the range of 01 to about 30%, more preferably about 0.01 to about 20%, and even more preferably about 0.01 to about 10%.
- susceptible disease means all diseases that are prevented or treated by glycosyl hesperetin.
- diseases for example, viral diseases, bacterial diseases, traumatic diseases, immune diseases that are prevented or treated by glycosyl hesperetin.
- Glycosyl hesperetin sensitive diseases such as sex diseases, rheumatism, diabetes, allergic diseases, dyslipidemia, cardiovascular diseases, malignant tumors and the like.
- the preventive and therapeutic agents for glycosyl hesperetin-sensitive diseases can be appropriately selected according to the purpose, for example, sprays, eye drops, nasal drops, gargles, injections and other liquids, ointments, haps, Examples thereof include pastes such as creams, and solids such as powders, powders, granules, tablets, and capsules.
- other ingredients such as medicinal ingredients, physiologically active substances, antibiotics, adjuvants, bulking agents, excipients, stabilizers, coloring agents, flavoring agents, preservatives, if necessary, It is also optional to use one or more of bactericides and bacteriostatic agents in combination.
- the dosage of the glycosyl hesperetin of the present invention can be appropriately adjusted depending on the content, administration route, administration frequency, symptoms and the like.
- the glycosyl hesperetin of the present invention is about 0.001 to about 10 g, preferably about 0.01 to about 5 g, more preferably about 0.05 to about about 5 g per day in terms of dry solids. Used in the range of 1 g.
- glycosyl hesperetin of the present invention As a method of blending the glycosyl hesperetin of the present invention into various compositions, known processes such as mixing, kneading, dissolution, dipping, infiltration, spraying, application, spraying, injection, etc. are required until these various compositions are completed. These methods can be used alone or in appropriate combination.
- the various compositions include, for example, foods and drinks, luxury products, cosmetics, pharmaceuticals (sensitive agent, etc.), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities) ), Or a plastic product.
- glycosyl hesperetin of the present invention When the glycosyl hesperetin of the present invention is blended with the above-mentioned various compositions, compared with the blend of the conventional product, even when kept or stored for several tens of minutes to several months in the above-mentioned temperature range, it is misty and colored. Of course, the odor is effectively reduced significantly.
- the glycosyl hesperetin of the present invention is not only a vitamin P fortifier, as in the conventional product, but also a high-quality and safe natural antioxidant, stabilizer, quality improver, preventive agent, therapeutic agent, Or as a ultraviolet absorber etc., it can utilize advantageously for various compounds or compositions.
- glycosyl hesperetin of the present invention will be described in more detail by experiments.
- Example 1 Physical Properties of Powdered Glycosyl Hesperetin>
- four types of sodium pyrosulfite as a reducing agent were used in the same manner as in the method of Example 1, except that 0.1, 0.09, 0.07, or 0.04% was used.
- Powdered glycosyl hesperetin (test samples 5 to 8: the present invention) was prepared, and as a control, in the methods of Examples 1, 3, 4, and 5, except that no reducing agent was used, Similarly, four types of powdered glycosyl hesperetins (test samples 1 to 4: conventional products) were prepared. Of the test samples 1 to 4, the test sample 1 is equivalent to the powdered glycosyl hesperetin obtained in Reference Example 1 described later.
- GC / MS analysis conditions > GC / MS analyzer: “Claras SQ8T GC / MS” (Perkin Elmer) Column: VF-WAXms [column length 30 m ⁇ inner diameter 0.25 mm, film thickness 0.25 ⁇ m] (manufactured by AGILENT J & W) ⁇ Detector: Mass spectrometer ⁇ Carrier: Helium gas ⁇ Linear velocity: 35 cm / sec ⁇ Temperature raising condition: Hold at 40 ° C. for 3 minutes, raise temperature from 40 ° C. to 80 ° C. at a rate of 5 ° C./min, 80 ° C. The temperature is raised from 10 to 200 ° C.
- the 4-VA content was measured using the following reagents, procedures, and apparatus. In addition, the measurement method was carried out according to “Notice of Benzene in Soft Drinks” dated July 28, 2006, notification of director of food safety department, Food Safety Department, Ministry of Health, Labor and Welfare No. 0728008.
- spectrophotometric total (trade name "UV-2600", manufactured by Shimadzu Corporation) absorbance at a wavelength of 420nm by the (OD 420nm) and absorbance at a wavelength of 720nm (OD 720nm) was measured, and the difference in absorbance at both wavelengths (OD 420nm -OD 720nm) The value was determined as the coloring degree.
- test samples 1 to 8 were dissolved in pure water so as to be a 1 w / w% aqueous solution, heated at 100 ° C. for 30 minutes in a sealed container, cooled to 20 ° C., and 20 ° C. The electrical conductivity was measured with an electrical conductivity meter (trade name “CM-50AT”, manufactured by Toa DKK Corporation).
- CM-50AT electrical conductivity meter
- the content of the cationic metal element was determined by the following method as a simple method. That is, for each of the test samples 1 to 8, approximately 0.5 g is precisely weighed in a 50 mL container (trade name “Falcon Tube”, manufactured by Nippon Becton Dickinson), dissolved in 20 mL of ultrapure water, and used for precision analysis. After adding 0.54mL of 60w / w% nitric acid aqueous solution, heating at 70 ° C for 14 hours and cooling to room temperature, the total amount is made 50mL with ultrapure water. Asked. As a control, only ultrapure water was used.
- test samples 1 to 4 were all over 300 ppb, whereas all of test samples 5 to 8 were about 10 ppb. Further, the 4-VA contents of test samples 1 to 4 were all over 40 ppb, whereas the test samples 5 to 8 were all about 2 ppb or less.
- the color tone (by visual observation) of the aqueous solutions of test samples 1 to 4 was pale yellow, but the aqueous solutions of test samples 5 to 8 (invention) were clearer than the control. The color was pale.
- the degree of coloration by the spectrophotometer was 0.24 or more for all of the aqueous solutions of the test samples 1 to 4, whereas the aqueous solutions of the test samples 5 to 8 were all 0.20 or less. It was low.
- the coloring degree of the test samples 5 to 8 showed a lower value as the amount of the reducing agent used was larger.
- the electrical conductivity of the aqueous solutions of test samples 1 to 4 was about 11 to about 12 ⁇ S / cm and over 10 ⁇ S / cm, whereas the aqueous solutions of test samples 5 to 8 were About 3 to about 7 ⁇ S / cm and less than 10 ⁇ S / cm.
- the glycosyl hesperetin of the present invention produced by using a reducing agent has significantly reduced furfural content, 4-VA content and coloring degree as compared with the conventional product, and the electrical conductivity and metal element content are also clear. Has been found to be reduced.
- test samples 5 to 8 used in Experiment 1 As representative examples of glycosyl hesperetin of the present invention, among test samples 5 to 8 used in Experiment 1, the content of furfural, coloration, electrical conductivity, and metal element content
- the test sample 6 which showed the value located in the middle of each, and as a typical example of the conventional product, among the test samples 1 to 4 used in Experiment 1, the furfural content, coloring degree, electrical conductivity, and metal element content are Using the test sample 1 that showed the lowest value, the sensory test shown in the following (2) was performed using 8 healthy men and women (2 women and 6 men) aged 28 to 59 years.
- test sample 1 and the glycosyl hesperetin (test sample 6) of the present invention are each dissolved in RO water (water that has passed through a reverse osmosis membrane) at room temperature so as to be a 1 w / w% aqueous solution.
- Test samples 1 and 6 were stored in a sealed container until the following test.
- each of the non-heated test samples 1 and 6 was sealed in a container, heated in a boiling water bath for 30 minutes, and cooled to room temperature (hereinafter referred to as “heat treatment”). It was.
- each panelist adjusted the room temperature to the non-heated test samples 1 and 6 (each 10 mL) and the heated test samples 1 and 6 (each 10 mL) obtained in (1). Each was evaluated for a) coloring and (b) odor. Thereafter, each panelist was asked to boil their mouth with white hot water before tasting each test sample, and then (c) bitterness (including astringency, gummy, astringent taste), (d) aftertaste, and (e) Each person was evaluated about the odor at the time of tasting.
- the evaluation criteria are as shown in the following Table 2 (in the table, “conventional product” means “test sample 1”).
- the non-heated test sample 6 is a control.
- the heated test sample 6 was used as a control, and the panelists were evaluated for the evaluation items (a) to (e). The results are shown in Table 3 and Table 4, respectively.
- the evaluation results shown in Tables 3 and 4 include (a) coloring, (b) odor, (c) bitterness, (d) aftertaste, and the conventional product (heated / non-heated test sample 1: control) itself.
- E Although the evaluation result of odor is not shown, as shown in the evaluation criteria, the evaluation results shown in Table 3 and Table 4 are those obtained by evaluating the glycosyl hesperetin of the present invention based on the conventional products.
- the evaluation result of the product is “3” in the middle in terms of the score (five-level evaluation) shown in the evaluation standard for each evaluation item.
- the non-heated test sample 6, that is, the glycosyl hesperetin of the present invention that has not been heat-treated is (a) colored, (b) odor, (c) bitterness, (d
- the number of panels evaluated as the highest “1” in the five-step evaluation was 4, 3, 3, 0 and 4, respectively. (14 people in total).
- the heated test sample 6 shown in the evaluation results of Table 4 that is, the heat-treated glycosyl hesperetin of the present invention has (a) coloring, (b) odor, (c) bitterness, (d) aftertaste, and (e)
- the glycosyl hesperetin of the present invention is a high-quality glycosyl hesperetin in which not only miscellaneous taste and color but also odor is effectively reduced as compared with conventional products.
- the non-heated test sample 6 (the glycosyl hesperetin of the present invention that has not been heat-treated) has (a) coloring, (b) odor, (c) bitterness, (d
- the heated test sample 6 (heat-treated glycosyl hesperetin of the present invention) was (a) colored, (b) odor, (c) bitter, (d) aftertaste, and ( e) Regarding the odor evaluation items, the number of panels evaluated as “5”, which is the lowest in the 5-level evaluation, and “4”, which is one level higher than the lowest level, was 0 (total 0).
- the glycosyl hesperetin of the present invention is a high-quality glycosyl hesperetin in which not only miscellaneous taste and color but also odor is effectively reduced as compared with conventional products.
- the glycosyl hesperetin of the present invention is (a) colored, (b) odor, (c) bitterness, (d) aftertaste, and (e) odor, regardless of heating / non-heating compared with the conventional product. It was clarified that all the evaluation items were excellent, and the difference in superiority and inferiority appeared as a more significant difference when heated.
- test samples 5, 7, and 8 shown in “(1) Preparation of test sample” of Experiment 2 were also subjected to the same sensory test as “(2) Sensory test” of Experiment 2, and the test sample was tested. A result almost equal to 6 was obtained.
- the glycosyl hesperetin of the present invention has significantly reduced bitterness (including astringency, igumi, and astringent taste) and aftertaste, that is, miscellaneous taste, and coloration significantly reduced. Turned out to be. Furthermore, it has been found that the odor of the glycosyl hesperetin of the present invention is significantly reduced as compared with the conventional product.
- sample A the glycosyl hesperetin of the present invention
- sample B the conventional product
- Coloring determination test 9 healthy males and females (2 females, 7 males) aged 28 to 57 years old were used as panels, and test samples 9 to 11 and Sample B (hereinafter referred to as “control”) were used.
- An evaluation test for coloring was performed. That is, each of the test samples 9 to 11 and the control were dissolved in distilled water at room temperature so as to be a 1 w / w% aqueous solution, and they were visually observed by each panelist, and each panelist compared with the control for each test sample. When it was evaluated that “coloring was reduced”, it was determined as “determination A1”, and when it was evaluated “not colored”, it was determined as “determination B1”.
- test samples 5 to 8 which are glycosyl hesperetins of the present invention and powdered glycosyl hesperetin of Examples 1 to 7 (hereinafter collectively referred to as “test samples of the present invention”) is 191 ppb.
- test samples of the present invention the furfural content of test samples 5 to 8 which are glycosyl hesperetins of the present invention and powdered glycosyl hesperetin of Examples 1 to 7 (hereinafter collectively referred to as “test samples of the present invention”) is 191 ppb.
- the 4-VA content was 28.7 ppb or less, and all of them had a significantly reduced miscellaneous taste peculiar to conventional products.
- control test sample the furfural content of the test samples 1 to 4 of the controls 1 to 5 and the powdered glycosyl hesperetin of Reference Example 1 (hereinafter collectively referred to as “control test sample”) is 308 ppb or more, 4-VA The content was 40.0 ppb or more, and all of them had a taste peculiar to conventional products.
- the glycosyl hesperetin of the present invention has a significantly reduced miscellaneous taste as compared with the conventional product, and further has a markedly reduced coloring and odor. It is extremely useful as a food and drink with reduced, coloring, and even odor, and is it not possible to use conventional products because of the miscellaneous taste, or because of miscellaneous taste and coloring, and also because of the odor? , Inevitably reduced quality, various foods and beverages, luxury products, cosmetics, pharmaceuticals (sensitive agents, etc.), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods ( (Including daily necessities) and plastic products can be used without problems.
- DE20 dextrin
- the name “Glucoteam” (manufactured by Nagase ChemteX Corporation) was added at 100 units per gram of the solid content of the enzyme reaction solution and reacted for 5 hours while maintaining the pH at 5.0 and 55 ° C. to produce ⁇ -glucosyl hesperidin.
- the resulting enzyme reaction solution is heated to inactivate the remaining enzyme, filtered, and the filtrate is applied to a column packed with a porous synthetic adsorbent, trade name “Diaion HP-10” (Mitsubishi Chemical Corporation). The solution was passed through SV2.
- the furfural content of this product was 12 ppb
- the 4-VA content was 2 ppb
- the coloring degree was 0.19
- the electrical conductivity was about 6 ⁇ S / cm.
- the product contained about 0.4 ppm, about 0.05 ppm, about 0.1 ppm, and about 0.1 ppm of calcium, potassium, magnesium, and sodium, respectively, per dry solid.
- this product has significantly reduced miscellaneous taste, remarkably reduced coloring and odor, and after heating for 30 minutes at a relatively high temperature of 90 to 100 ° C.
- the miscellaneous taste is significantly reduced, but also the coloring and odor are effectively reduced significantly. Therefore, foods and beverages, cosmetics, pharmaceuticals (such as sensitive diseases), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), or plastics containing this product
- the miscellaneous taste is significantly reduced compared to the case of using the conventional product, and further, coloring and odor are remarkable.
- this product is not only as a vitamin P fortifier like the conventional product, but also as a highly safe natural type antioxidant, stabilizer, quality improver, preventive agent, therapeutic agent, ultraviolet absorber, etc.
- Food and drink luxury goods, feed, feed, cosmetics, pharmaceuticals (sensitive agents, etc.), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), or plastic products It can be advantageously used in various compositions such as.
- the solution was dissolved with stirring for 30 minutes, neutralized with a 0.01 N hydrochloric acid solution, and immediately followed by Geobacillus stearothermophilus Tc-91 strain (Independent Administrative Institution, National Institute of Technology and Evaluation, Patent Biodeposition Center) No.
- FERM BP-11273 -derived CGTase was added at 20 units per gram of dextrin, maintained at pH 6.0, 75 ° C., and allowed to react for 24 hours with stirring.
- the obtained enzyme reaction solution was sampled and analyzed by HPLC. As a result, about 69% of hesperidin was converted to ⁇ -glycosyl hesperidin.
- sodium pyrosulfite as a reducing agent was added to the obtained enzyme reaction solution to 0.03% and heated at 90 ° C. for 120 minutes, followed by glucoamylase (trade name “Glucoteam”, Nagase ChemteX Corporation).
- purified water is passed through the column, the column is washed, and further passed while increasing the concentration of the aqueous ethanol solution stepwise.
- the fraction containing ⁇ -glucosyl hesperidin is collected, concentrated under reduced pressure, powdered, Pale yellow powdered glycosyl hesperetin was obtained in a yield of about 68% based on the mass of raw material hesperidin per solid.
- the powdered glycosyl hesperetin obtained in this example contained 77.0% ⁇ -glucosyl hesperidin, 15.5% hesperidin, and 7.5% other components.
- the furfural content of this product was 11 ppb, the 4-VA content was 1.5 ppb, the coloring degree was 0.14, and the electrical conductivity was about 4 ⁇ S / cm. Moreover, this product contained about 0.4 ppm, about 0.06 ppm, about 0.1 ppm, and about 0.1 ppm of calcium, potassium, magnesium, and sodium, respectively, per dry solid.
- this product has significantly reduced miscellaneous taste, remarkably reduced coloring and odor, and after heating for 30 minutes at a relatively high temperature of 90 to 100 ° C.
- the miscellaneous taste is significantly reduced, but also the coloring and odor are effectively reduced significantly. Therefore, foods and beverages, cosmetics, pharmaceuticals (such as sensitive diseases), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), or plastics containing this product
- the miscellaneous taste is significantly reduced compared to the case of using the conventional product, and further, coloring and odor are remarkable.
- this product is not only as a vitamin P fortifier like the conventional product, but also as a highly safe natural type antioxidant, stabilizer, quality improver, preventive agent, therapeutic agent, ultraviolet absorber, etc.
- Various compositions such as food and drink, luxury goods, cosmetics, drugs (sensitive agents, etc.), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), or plastic products It can be used to advantage.
- FERM BP-11273 was added per gram of dextrin and maintained at pH 6.0 and 75 ° C. and reacted for 24 hours, about 72% of hesperidin was found to be It was converted to ⁇ -glycosyl hesperidin.
- the resulting enzyme reaction solution is heated to inactivate the remaining enzyme, filtered, and the filtrate is applied to a column packed with a porous synthetic adsorbent, trade name “Diaion HP-20” (sold by Mitsubishi Chemical Corporation). The solution was passed through SV2.
- the furfural content of this product was 10 ppb, the 4-VA content was 3.0 ppb, the coloring degree was 0.17, and the electric conductivity was about 4 ⁇ S / cm. Further, this product contained about 0.3 ppm, about 0.04 ppm, about 0.1 ppm and about 0.05 ppm of calcium, potassium, magnesium and sodium, respectively, per dry solid.
- this product has significantly reduced miscellaneous taste, remarkably reduced coloring and odor, and after heating for 30 minutes at a relatively high temperature of 90 to 100 ° C.
- the miscellaneous taste is significantly reduced, but also the coloring and odor are effectively reduced significantly. Therefore, foods and beverages, cosmetics, pharmaceuticals (such as sensitive diseases), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), or plastics containing this product
- the miscellaneous taste is significantly reduced compared to the case of using the conventional product, and further, coloring and odor are remarkable.
- this product is not only as a vitamin P fortifier like the conventional product, but also as a highly safe natural type antioxidant, stabilizer, quality improver, preventive agent, therapeutic agent, ultraviolet absorber, etc.
- Food and drink luxury goods, cosmetics, pharmaceuticals (anti-sensitive diseases, etc.), quasi drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), and plastic products It can be advantageously used in the composition.
- CGTase derived from stearothermophilus Tc-91 strain National Institute of Technology and Evaluation, Patent Biodeposition Center accession number FERM BP-11273
- the powdered glycosyl hesperetin obtained in this example is composed of 81.9% ⁇ -glucosyl hesperidin, 0.5% hesperidin, 8.9% 7-O- ⁇ -glucosyl hesperetin, and 8.7% other components. % Content.
- the furfural content of this product was 9 ppb, the 4-VA content was 2.0 ppb, the coloring degree was 0.16, and the electric conductivity was about 4 ⁇ S / cm.
- the product contained about 0.3 ppm, about 0.03 ppm, about 0.05 ppm, and about 0.05 ppm of calcium, potassium, magnesium, and sodium, respectively, per dry solid.
- this product has significantly reduced miscellaneous taste, remarkably reduced coloring and odor, and after heating for 30 minutes at a relatively high temperature of 90 to 100 ° C.
- the miscellaneous taste is significantly reduced, but also the coloring and odor are effectively reduced significantly. Therefore, foods and beverages, cosmetics, pharmaceuticals (such as sensitive diseases), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), or plastics containing this product
- the miscellaneous taste is significantly reduced compared to the case of using the conventional product, and further, coloring and odor are remarkable.
- this product is not only as a vitamin P fortifier like the conventional product, but also as a highly safe natural type antioxidant, stabilizer, quality improver, preventive agent, therapeutic agent, ultraviolet absorber, etc.
- Food and drink luxury goods, cosmetics, pharmaceuticals (anti-sensitive diseases, etc.), quasi drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), and plastic products It can be advantageously used in the composition.
- ⁇ Powdered glycosyl hesperetin> Hesperidin 50 parts by mass and 1 part by mass of sodium hyposulfite as a reducing agent are dissolved in 90 parts by mass of a 0.25N aqueous sodium hydroxide solution at 80 ° C., 150 parts by mass of DE8 dextrin is added and dissolved, and the pH is adjusted to 9.0. After the adjustment, CGTase derived from Geobacillus stearothermophilus Tc-91 strain (Independent Administrative Institution Product Evaluation Technology Foundation, Patent Biodeposition Center Accession No. FERM BP-11273) was added at 15 units per 1 part by mass of dextrin, and 60 The solution was adjusted to pH 8.3 while heating up to 0 ° C.
- glucoamylase (trade name “Glucoteam”, manufactured by Nagase ChemteX Corporation) was added, and the mixture was further reacted at 55 ° C. for 24 hours.
- the resulting enzyme reaction solution is heated to inactivate the enzyme, and applied to a column packed with a medium polarity porous adsorption resin (trade name “Amberlite XAD-7”, manufactured by Rohm and Haas).
- the column was washed with water, and the resin adsorbing component was eluted with an 80 v / v% aqueous ethanol solution. After removing the ethanol in the eluate, it was freeze-dried, 82.0% ⁇ -glucosyl hesperidin, 8.0% 7-O- ⁇ -glucosyl hesperetin, 1.0% hesperidin, and other components 9 A powdered glycosyl hesperetin containing 0.0% was obtained.
- This product had a furfural content of 10 ppb, a 4-VA content of 1.5 ppb, a coloring degree of 0.15, and an electric conductivity of less than 10 ⁇ S / cm. Moreover, this product contained about 0.4 ppm, about 0.04 ppm, about 0.1 ppm and about 0.2 ppm of calcium, potassium, magnesium and sodium, respectively, per dry solid.
- this product has significantly reduced miscellaneous taste, remarkably reduced coloring and odor, and after heating for 30 minutes at a relatively high temperature of 90 to 100 ° C.
- the miscellaneous taste is significantly reduced, but also the coloring and odor are effectively reduced significantly. Therefore, foods and beverages, cosmetics, pharmaceuticals (such as sensitive diseases), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), or plastics containing this product
- the miscellaneous taste is significantly reduced compared to the case of using the conventional product, and further, coloring and odor are remarkable.
- this product is not only as a vitamin P fortifier like the conventional product, but also as a highly safe natural type antioxidant, stabilizer, quality improver, preventive agent, therapeutic agent, ultraviolet absorber, etc.
- Food and drink luxury goods, cosmetics, pharmaceuticals (anti-sensitive diseases, etc.), quasi drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), and plastic products It can be advantageously used in the composition.
- ⁇ Powdered glycosyl hesperetin> The light yellow powdered glycosyl hesperetin was added to the enzyme reaction liquid in an amount of about 69 based on the mass of hesperidin per raw material in the same manner as in Example 1 except that 0.001% of potassium metasulfite as a reducing agent was added. % Yield.
- the powdered glycosyl hesperetin obtained in this example contained 79.5% ⁇ -glucosyl hesperidin, 13.8% hesperidin, and 6.7% other components.
- This product had a furfural content of 180 ppb, a 4-VA content of 20 ppb, a coloration degree of 0.23, and an electrical conductivity of less than 10 ⁇ S / cm. Moreover, this product contained about 0.5 ppm, about 0.08 ppm, about 0.1 ppm, and about 0.3 ppm of calcium, potassium, magnesium, and sodium, respectively, per dry solid.
- this product is inferior to the powdered glycosyl hesperetin obtained in Examples 1 to 5, the miscellaneous taste is significantly reduced and the coloring and odor are also significantly reduced compared to the conventional product. Even after heating for 30 minutes at a relatively high temperature of 90 to 100 ° C., not only the taste is significantly reduced, but also coloring and odor are effectively reduced significantly compared to the conventional product. It has excellent properties.
- this product is not only as a vitamin P fortifier like the conventional product, but also as a highly safe natural type antioxidant, stabilizer, quality improver, preventive agent, therapeutic agent, ultraviolet absorber, etc.
- compositions such as food and drink, luxury products, cosmetics, pharmaceuticals (sensitive agents, etc.), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), and plastic products It can be used to advantage.
- ⁇ Powdered glycosyl hesperetin> In the same manner as in Example 6 except that potassium metasulfite was replaced with sodium hydrogen sulfite, a light yellow powdery glycosyl hesperetin was obtained in a yield of about 65% based on the mass of raw material hesperidin per dry solid. .
- the powdered glycosyl hesperetin obtained in this example contained 77.2% ⁇ -glucosyl hesperidin, 16.5% hesperidin, and 6.3% other components.
- This product had a furfural content of 191 ppb, a 4-VA content of 28.7 ppb, a coloration degree of 0.23, and an electrical conductivity of less than 10 ⁇ S / cm. Moreover, this product contained about 0.5 ppm, about 0.07 ppm, about 0.09 ppm, and about 0.4 ppm of calcium, potassium, magnesium, and sodium, respectively, per dry solid.
- this product is inferior to the physical properties of the powdered glycosyl hesperetin obtained in Examples 1 to 5, this product has a significantly reduced miscellaneous taste and significant coloring and odor compared to the conventional product.
- coloring and odor are also effective as well as significantly reduced taste compared to conventional products. It has excellent characteristics that are significantly reduced.
- this product is not only as a vitamin P fortifier like the conventional product, but also as a highly safe natural type antioxidant, stabilizer, quality improver, preventive agent, therapeutic agent, ultraviolet absorber, etc.
- compositions such as food and drink, luxury products, cosmetics, pharmaceuticals (sensitive agents, etc.), quasi-drugs, chemicals, industrial raw materials and materials, feed, feed, clothing, miscellaneous goods (including daily necessities), and plastic products It can be used to advantage.
- this method is an extremely simple method in which a reducing agent is simply added to the powdered glycosyl hesperetin obtained in Reference Example 1, it has an excellent advantage that the miscellaneous taste peculiar to conventional products can be significantly reduced. ing.
- the powdered glycosyl hesperetin obtained by this method has not only a significant reduction in miscellaneous taste, but also a marked reduction in coloring and odor. Therefore, the powdered glycosyl hesperetin is incorporated into various foods and drinks. Even when heat-treated or in a solution state and then heat-stored for a relatively long period of time, coloring and odor are effectively remarkably reduced, not to mention miscellaneous taste caused by this product.
- ⁇ Mixed sweetener 100 parts by mass of isomerized liquid sugar, 2 parts by mass of sugar, and 1 part by mass of powdered glycosyl hesperetin obtained by the method of Example 1 were heat-treated at 80 ° C. for 30 minutes to obtain a vitamin P-enriched liquid mixed sweetener.
- This product is a vitamin P-enhanced liquid mixed sweetener with effectively reduced miscellaneous taste, coloring and odor peculiar to conventional products. Therefore, even when various foods and drinks are cooked using this product, there is an advantage that the flavor and color tone of the food and drink materials are not impaired because the miscellaneous taste, coloring and odor caused by this product are not concerned. It is made.
- ⁇ Hard candy> Concentrate 10 parts by mass of ⁇ , ⁇ -trehalose (registered trademark “Treha”, sold by Hayashibara Co., Ltd.) and 20 parts by mass of water under reduced pressure of 155 ° C. until the water content is about 2% or less, and then to 120 ° C. After cooling, 0.5 parts by mass of citric acid and 0.01 parts by mass of powdered glycosyl hesperetin obtained by the method of Example 2 and a lemon flavor were mixed in an appropriate amount. Reinforced hard candy was obtained.
- this product effectively reduces the special taste, coloration, and odor characteristic of conventional products, impairing the flavor of lemon and the transparency of hard candy. Vitamin P fortified hard candy.
- This product is in high-quality blood that does not substantially increase or change miscellaneous taste, coloration, or odor caused by this product even after storage at room temperature or above room temperature for a relatively long period of time. It can be advantageously used as a cholesterol-lowering agent, immunostimulant, skin-beautifying agent, etc., as a prophylactic agent, a therapeutic agent, and a food for health promotion.
- This product is diluted 100 to 10,000 times in hot water for bathing.
- the hot water for bathing is a circulation type, the coloring and odor caused by this product increase or after 1 hour or more after the product has been added to the hot water, compared to immediately after the addition. It is a high-quality bath preparation that does not substantially change, and does not impair the fragrance of the fragrance added to the product.
- ⁇ Emulsion> 0.5 parts by mass of polyoxyethylene behenyl ether, 1 part by mass of polyoxyethylene sorbitol tetraoleate, 1 part by mass of lipophilic glyceryl monostearate, 0.5 parts by mass of pyruvic acid, 0.5 parts by mass of behenyl alcohol, avocado oil 1 part by weight, 1 part by weight of powdered glycosyl hesperetin obtained by the method of Example 1, appropriate amounts of vitamin E and preservatives were dissolved by heating according to a conventional method, and 1 part by weight of L-sodium lactate, 1,3- An emulsion was prepared by adding 5 parts by weight of butylene glycol, 0.1 part by weight of carboxyvinyl ponmer and 85.3 parts by weight of purified water, emulsifying with a homogenizer, adding an appropriate amount of fragrance, stirring and mixing.
- the product Even if the product is stored at room temperature or slightly above room temperature for a relatively long period of time, it does not substantially increase or change the miscellaneous taste, coloration, or odor caused by the product, and is incorporated into the product. It is a high-quality emulsion that does not impair the fragrance of the perfume.
- any of these products can be stored in a room temperature or relatively high temperature environment for several tens of minutes to several months, and then added to beverages such as green tea, tea, coffee, cocoa, etc. It is a vitamin P fortifier excellent in storage stability and heat stability, in which increase or change in miscellaneous taste, coloring and odor is not substantially observed.
- This product Since this product has effectively reduced taste, coloring and odor, it can be taken orally on a daily basis without discomfort.
- This product can be taken orally on a daily basis by adding 1 or 2 packs thereof to various beverages such as water, tea, tea, and coffee and other foods and drinks per day.
- this product Since this product has reduced miscellaneous taste, coloring and odor, it can be taken orally on a daily basis without discomfort. By daily oral intake of this product at 50 to 200 mL per day, the skin can be maintained in a healthy state.
- the furfural content of this product was 310 ppb, the 4-VA content was 40 ppb, the coloring degree was 0.24, and the electric conductivity was about 11 ⁇ S / cm.
- the product contained about 3 ppm, about 0.2 ppm, about 0.4 ppm, and about 1 ppm of calcium, potassium, magnesium, and sodium, respectively, per dry solid.
- glycosyl hesperetin produced without using the reducing agent used in the present invention was clearly inferior at least in terms of miscellaneous taste, coloring and odor, compared to the glycosyl hesperetin according to the present invention.
- the miscellaneous taste is significantly reduced, and the glycosyl hesperetin of the present invention, in which coloring and odor are remarkably reduced, is simply the addition of a reducing agent in any step in the manufacturing process of conventional products. Because it can be stably provided in large quantities and at low cost industrially, not only in the fields where the conventional products have been applied, but also for the miscellaneous taste peculiar to the conventional products, or for the miscellaneous taste and coloring, and also for the odor. Even in areas where application is difficult or hindered, it can be easily applied without hindrance. Thus, the influence of the present invention on the world is enormous, and the industrial applicability of the present invention is extremely large.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
・HPLC装置:『LC-20AD』(株式会社島津製作所製)
・デガッサー:『DGU-20A3』(株式会社島津製作所製)
・カラム:『CAPCELL PAK C18 UG 120』(株式会社資生堂製)
・サンプル注入量:10μ1
・溶離液:水/アセトニトリル/酢酸(80/20/0.01(容積比))
・流 速:0.7m1/分
・温 度:40℃
・検 出:UV検出器『SPD-20A』(株式会社島津製作所製)
・測定波長:280nm
・データ処理装置:『クロマトパックC-R7A』(株式会社島津製作所製)
(1)ヘスペリジン含量:HPLCにて分析し、そのピーク面積と、所定濃度の標準物質の試薬ヘスペリジン(和光純薬工業株式会社販売)のピーク面積との比に基づいて算出する。
(2)α-グルコシルヘスペリジン含量:HPLCにて分析し、そのピーク面積と、所定濃度の標準物質の試薬ヘスペリジン(和光純薬工業株式会社販売)のピーク面積との比と、α-グルコシルヘスペリジンとヘスペリジンの分子量比に基づいて算出する。
(3)7-O-β-グルコシルヘスペレチン含量:HPLCにて分析し、そのピーク面積と、所定濃度の標準物質の試薬ヘスペリジン(和光純薬工業株式会社販売)のピーク面積との比と、7-O-β-グルコシルヘスペレチンとヘスペリジンの分子量比に基づいて算出する。
(4)その他のグリコシルヘスペレチン含量:HPLCにて分析し、そのピーク面積と、所定濃度の標準物質の試薬ヘスペリジン(和光純薬工業株式会社販売)のピーク面積との比と、その他のグリコシルヘスペレチンとヘスペリジンとの分子量比に基づいて算出する。
製造原料のヘスペリジンとしては、従来品の製造において用いられるヘスペリジンのいずれも用いることができ、高純度のヘスペリジンはもとより、比較的低純度のヘスペリジン含有植物由来の抽出物、搾汁液、又はその部分精製物などの1種又は2種以上を適宜組み合わせて用いることができる。前記ヘスペリジン含有植物とは、例えば、ミカン類、オレンジ類、香酸柑橘類、雑柑橘類、タンゴール類、タンゼロ類、ブンタン類、キンカン類、ダイダイ類などのミカン科ミカン属に属する柑橘類を例示でき、ヘスペリジン含有部位としては、それらの果実、果皮、種子、未熟果などを例示できる。
本発明で言う酵素反応とは、前記製造原料としてのヘスペリジンと澱粉部分分解物に糖転移酵素を作用させてα-グリコシルヘスペリジンを生成させる酵素反応を意味する。
還元剤処理とは、還元剤を用いて、グリコシルヘスペレチンの雑味を有意に低減させるための処理を意味し、後述する還元剤を、(ア)ヘスペリジン及び澱粉部分分解物を含有する水溶液を調製する工程、(イ)得られた水溶液に糖転移酵素を作用させα-グルコシルヘスペリジンを含むグリコシルヘスペレチンを生成させる工程、及び(ウ)生成したグリコシルヘスペレチンを採取する工程の1又は2以上の工程で用いるか、前記(ア)乃至(ウ)の1又は2以上の工程の前の始発原料及び/又は前記工程後の結果物に、その所定量を添加することを意味する。
斯くして得られる酵素反応溶液は、そのまま、本発明のグリコシルヘスペレチンとして用いることができる。しかし、通常、酵素反応溶液は、斯界において公知の分別方法、濾過方法、多孔性合成樹脂等を用いる精製方法、濃縮方法、噴霧方法、乾燥方法などの1種又は2種以上の手段を適宜組み合わせて、液状、固状、粉末状などの形態にあるグリコシルヘスペレチンとすることができる。
(2)本発明のグリコシルヘスペレチンの製造工程において、還元剤が、雑味の原因物質が生成するのを低減ないしは抑制するか、生成した雑味の原因物質をマスク、分解ないしは修飾され、雑味が有意に低減されたグリコシルヘスペレチンが得られる。
(3)前記(1)及び(2)に示す雑味の原因物質が還元剤により修飾を受け、多孔性合成吸着剤などによる精製工程でグリコシルヘスペレチンと分離し易くなり、その結果、雑味が有意に低減されたグリコシルヘスペレチンが得られる。
後述する実施例1の方法において、還元剤としてのピロ亜硫酸ナトリウムを0.1、0.09、0.07又は0.04%用いた以外は、実施例1の方法と同様にして4種類の粉末状グリコシルヘスペレチン(被験試料5乃至8:本発明)を調製するとともに、対照として、実施例1、3、4、及び5の方法において、還元剤を用いない以外は、それら実施例の方法と同様にして4種類の粉末状グリコシルヘスペレチン(被験試料1乃至4:従来品)を調製した。なお、被験試料1乃至4の内、被験試料1は、後述する参考例1で得られた粉末状グリコシルヘスペレチンと同等品である。
被験試料1乃至8のそれぞれにつき、下記手順及び装置を用いてフルフラール含量を求めた。
(ア)50mL容共栓付三角フラスコに被験試料としての前記粉末状グリコシルヘスペレチンのいずれかを乾燥固形物換算で0.5g採取する。
(イ)次いで、脱イオン水5.0mLを各粉末状グリコシルヘスペレチンに加え溶解し、サロゲート物質(分析に際し、被験試料の回収率を調べるための指標)として、濃度0.0025%のシクロヘキサノール20μLを加える。
(ウ)更に、塩化ナトリウムを1.5g加え溶解し、ジエチルエーテル(試薬特級、和光純薬工業株式会社販売)を3mL加え、700rpmで10分間攪拌する。
(エ)全量を分液漏斗に移し取り、10分間静置した後、ジエチルエーテル相を回収し、硫酸ナトリウム無水塩にて脱水後、窒素気流下、約200μLとなるまで濃縮する。
(オ)濃縮液1μLを採取し、GC/MS分析装置に供する。
(カ)対照として、粉末状グリコシルヘスペレチンに代えて試薬級フルフラール(試薬特級、東京化成工業株式会社販売)を用いた以外は、被験試料と同様に、(ア)乃至(オ)の処理を行う。
・GC/MS分析装置:『Clarus SQ8T GC/MS』(パーキンエルマー社製)
・カラム:VF-WAXms [カラム長30 m×内径0.25 mm、膜厚0.25 μm](AGILENT J&W社製)
・検出器:質量分析器
・キャリアー:ヘリウムガス
・線速度35cm/秒
・昇温条件:40℃で3分間保持し、40℃~80℃まで5℃/分の割合で昇温し、80℃~200℃まで10℃/分の割合で昇温し、200℃で7分間保持し、200℃~220℃まで10℃/分の割合で昇温し、更に、220℃で8分間保持する。
・サロゲート物質:シクロヘキサノール(試薬一級、片山化学工業株式会社販売)
・内部標準物質:ヘンエイコサン(GC用標準物質、東京化成工業株式会社販売)
・抽出溶媒:ジエチルエーテル(試薬特級、和光純薬工業株式会社販売)
GC/MS分析法で得られた、対照の試薬特級フルフラール(和光純薬株式会社販売)についての測定データを元に検量線を作成し、これに基づいて、被験試料のフルフラール含量を求めた。
被験試料1乃至8それぞれにつき、下記試薬、手順、及び装置を用いて4-VA含量を測定した。なお、その測定方法は、平成18年7月28日付、食安基発第0728008号厚生労働省医薬食品局食品安全部基準審査課長通知『清涼飲料水中のベンゼンについて』に準じて行った。
(ア)塩化ナトリウム(水質試験用、和光純薬工業株式会社販売)
(イ)シクロヘキサノール標準原液の調製
シクロヘキサノール(試薬一級、片山化学工業株式会社販売)をメタノール(局方一般試験法用)に溶解して0.01質量%シクロヘキサノール溶液(以下、「シクロヘキサノール標準原液」と言う。)を調製した。
(ウ)内部標準液
前記シクロヘキサノール標準原液とメタノールを用いて、0.0004質量%シクロヘキサノール溶液(以下、「内部標準液1」と言う。)及び0.00004質量%シクロヘキサノール溶液(以下、「内部標準液2」と言う。)を調製した。
(エ)標準原液の調製
4-VA(和光純薬工業株式会社販売)をメタノールに溶解し、0.0005質量%4-VA溶液(以下、「標準液A」と言う。)及び0.00005質量%4-VA溶液(以下、「標準液B」と言う。)をそれぞれ調製した。
(オ)検量線作成用標準原液の調製
前記標準液A、B、前記内部標準液1、及びメタノールを用いて、4-VA濃度が0.05、0.1、0.2、0.5又は1.0μg/mLである5種類の検量線作成用混合標準原液を調製した。
(カ)検量線作成用標準液の調製
20mL容ヘッドスペースバイアル5本にそれぞれ超純水を10mL加え、更に前記5種類の検量線作成用混合標準原液のいずれかを10μL加え、更に塩化ナトリウム3.0gを添加し、直ちに密栓し、撹拌溶解し、5種類の検量線作成用標準液を調製した。
20mL容ヘッドスペースバイアル8本に被験試料1乃至8のいずれかを乾燥固形物換算で0.20g精秤し、これに超純水を加え全量を10.0gとし、撹拌溶解した。得られた水溶液に前記内部標準液2を10μL加え、更に塩化ナトリウムを3.0g添加し、直ちに密栓し、撹拌溶解し、被験試料1乃至8のいずれかを含む8種類の被験試料を調製した。
(ア)測定条件
<GC/MS分析条件>
・GC/MS分析装置:『Clarus SQ8T GC/MS』(パーキンエルマー社製)
・ヘッドスペースサンプラー:『TurboMatrix Trap 40』
・カラム:VF-WAXms [カラム長30 m×内径0.25 mm、膜厚0.25 μm)(AGILENT J&W社製)
・検出器:質量分析器
・キャリアー:ヘリウムガス
・線速度:35cm/秒
・カラム注入口温度:200℃
・昇温条件:40℃で3分間保持し、40℃~80℃まで5℃/分の割合で昇温し、80℃~200℃まで10℃/分の割合で昇温し、200℃で7分間保持し、200℃~220℃まで10℃/分の割合で昇温し、更に、220℃で8分間保持する。
・バイアルオーブン温度:60℃
・ニードル温度:140℃
・トランスファーライン温度:205℃
・バイアル加熱時間:30分間
<検出法>
・イオン化[Electron Impact(EI)]法
・SIM選択イオン(Selected Ion Monitoring)
m/z 134, 119 (4-VA)
m/z 82, 57 [シクロヘキサノール(試薬一級、片山化学工業株式会社販売)]
前記8種類の被験試料及び前記5種類の検量線作成用混合標準液における4-VAと内部標準(シクロヘキサノール)のピーク高さ比と、別途作成しておいた4-VAの検量線とに基づき、前記被験試料における4-VA濃度を求め、それに基づいて被験試料1乃至8における4-VA含量を算出した。
被験試料1乃至8の水溶液それぞれにつき、色調を肉眼観察するとともに、下記手順により、着色度を求めた。すなわち、被験試料1乃至8それぞれにつき、1w/w%水溶液とし、その40mLを密閉容器(50mL容)中で100℃で30分間加熱した後、27℃とし、幅1cmのセルに入れ、分光光度計(商品名『UV-2600』、島津製作所製)により波長420nmにおける吸光度(OD420nm)及び波長720nmにおける吸光度(OD720nm)を測定し、両波長における吸光度の差(OD420nm-OD720nm)を求め、その値を着色度とした。
被験試料1乃至8それぞれにつき、1w/w%水溶液となるように純水に溶解し、密閉容器中で100℃で30分間加熱した後、20℃に冷却し、20℃での電気伝導度を電気伝導度計(商品名『CM-50AT』、東亜ディーケーケー社製)により測定した。
イオン性化合物を定量することは容易ではないので、簡便法として、下記手法により、陽イオン金属元素の含量を求めた。すなわち、被験試料1乃至8それぞれにつき、約0.5gを50mL容器(商品名『ファルコンチューブ』、日本ベクトンディッキンソン社製)に精秤し、超純水20mLに加熱溶解し、これに精密分析用の60w/w%硝酸水溶液を0.54mL添加し、70℃で14時間加熱し、室温まで冷却した後、超純水にて全量を50mLとし、下記分析装置と測定条件下で金属元素含量を求めた。なお、対照は超純水のみを用いた。
・誘導結合プラズマ発光分光分析装置:『CIROS-120』
(Spectro社製)
・プラズマ電力:1,400W
・プラズマガス(Ar):13.0L/分
・補助ガス(Ar):1.0L/分
・ネブライザーガス(Ar):1.0L/分
・ポンプ動作:1.0mL/分
・金属元素含量(ppm)の算出方法:
{(被験試料の測定値)-(対照の測定値)}×希釈倍率
本発明のグリコシルヘスペレチンと従来品とを用いて、下記の官能試験を行った。
本発明のグリコシルヘスペレチンの代表例として、実験1で用いた被験試料5乃至8の内、フルフラール含量、着色度、電気伝導度、及び金属元素含量のそれぞれが中間に位置する値を示した被験試料6と、従来品の代表例として、実験1で用いた被験試料1乃至4の内、フルフラール含量、着色度、電気伝導度、及び金属元素含量が最も低値を示した被験試料1を用いて、28乃至59歳の健常な男女8人(女性2人、男性6人)をパネルとする下記(2)に示す官能試験を行った。すなわち、従来品(被験試料1)と本発明のグリコシルヘスペレチン(被験試料6)をそれぞれ1w/w%水溶液となるように室温でRO水(逆浸透膜を通した水)に溶解し、非加熱被験試料1、6とし、これらは下記試験に供するまで密閉容器中に保管した。また、非加熱被験試料1、6をそれぞれ、容器に入れ密閉し、沸騰水浴中で30分間加熱し、室温まで冷却した(以下、「加熱処理」と言う。)ものを加熱被験試料1、6とした。
(2)官能試験
各パネリストに、室温に調整した、前記(1)で得た非加熱被験試料1、6(各10mL)及び加熱被験試料1、6(各10mL)について、試飲前に、(a)着色と(b)臭気とを各自に評価させた。その後、各パネリストには、各被験試料を試飲する前に白湯で口を漱がせた後、(c)苦味(渋み、えぐみ、収斂味を含む)、(d)後味、及び(e)試飲時の臭気について各自に評価させた。評価基準は下記表2(表中、「従来品」とは、「被験試料1」を意味する。)に示すとおりであり、非加熱被験試料6に対しては、非加熱被験試料1を対照とし、加熱被験試料6に対しては、加熱被験試料1を対照とし、前記(a)乃至(e)の評価項目につき、各パネリストに評価させた。結果はそれぞれ、表3、表4に示す。
グリコシルヘスペレチンの雑味、着色と、フルフラール及び4-VAの含量との関係を調べる目的で下記の試験を行った。
後述する実施例4の方法及び参考例1の方法に準じて、本発明のグリコシルヘスペレチン(以下、「試料A」と言う。)と従来品(以下、「試料B」と言う。)とを調製した。次いで、便宜上、試料A、Bを適宜割合で配合し、フルフラール含量が段階的に異なる、表5に示す3種類のグリコシルヘスペレチン試料(以下、「被験試料9乃至11」と言う。)を調製した。
実験1の(1)と(2)に示す測定方法にしたがって、被験試料9乃至11のフルフラール含量と4-VA含量とをそれぞれ測定した。
28乃至57歳の健常な男女9人(女性2人、男性7人)をパネルとし、被験試料9乃至11及び試料B(以下、「対照」と言う。)を用いて着色についての評価試験を行った。すなわち、被験試料9乃至11及び対照をそれぞれ蒸留水に1w/w%水溶液となるように室温で溶解し、それらを各パネリストに肉眼観察させ、各パネリストが各被験試料につき、対照と比べ、「着色が低減されている」と評価した場合には「判定A1」、「着色が低減されていない」と評価した場合には「判定B1」と判定させ、その結果を表5に示した。
前記男女9人をパネルとし、被験試料9乃至11及び対照の雑味について官能試験を行った。すなわち、被験試料9乃至11及び対照をそれぞれ蒸留水に1w/w%水溶液となるように室温で溶解し、それらを各パネリストに試飲させ、各パネリストが、各被験試料につき対照と比べ、「雑味が改善されている」と評価した場合には「判定A2」、「雑味が改善されていない」と評価した場合には「判定B2」と判定させ、その結果を表5に示した。
1規定水酸化ナトリウム水溶液4質量部を80℃に加温し、この温度を維持しつつ、ヘスペリジン1質量部及びデキストリン(DE20)7質量部を加え、30分間撹拌しつつ溶解させ、pHを9.0とし、これにジオバチルス・ステアロサーモフィラス Tc-91株(日本国〒305-8566 茨城県つくば市東1丁目1番地1中央第6所在の独立行政法人 製品評価技術基盤機構 特許生物寄託センター 受託番号FERM BP-11273 寄託日:1973年7月30日)由来のCGTaseをデキストリングラム当り30単位加え、pH6.9、50℃に維持しつつ18時間反応させ、ヘスペリジンの約70%をα-グリコシルヘスペリジンに変換させた。次いで、得られた酵素反応液に対し、還元剤としてのピロ亜硫酸ナトリウムを0.05%添加し、100℃で30分間加熱するともに、残存する酵素を加熱失活させた後、グルコアミラーゼ(商品名『グルコチーム』、ナガセケムテックス社製)を酵素反応液の固形分グラム当り100単位加え、pH5.0、55℃に維持しつつ5時間反応させ、α-グルコシルヘスペリジンを生成させた。得られた酵素反応液を加熱して残存する酵素を失活させ、濾過し、濾液を多孔性合成吸着剤、商品名『ダイヤイオンHP-10』(三菱化学株式会社販売)を充填したカラムにSV2で通液した。その結果、溶液中のα-グルコシルヘスペリジンと未反応ヘスペリジンとが多孔性合成吸着剤に吸着し、D-グルコース、塩類などは吸着することなく流出した。次いで、カラムに精製水を通液し、カラムを洗浄した後、エタノール水溶液濃度を段階的に高めながら更に通液し、α-グルコシルヘスペリジン含有画分を採取し、減圧濃縮し、粉末化して、淡黄色の粉末状グリコシルヘスペレチンを固形物当り原料のヘスペリジン質量に対して約70%の収率で得た。なお、本例で得られた粉末状グリコシルヘスペレチンは、α-グルコシルヘスペリジン80.0%、ヘスペリジン12.3%、その他の成分を7.7%含有していた。
1規定水酸化ナトリウム水溶液4質量部を80℃に加温し、この温度を維持しつつ、これにヘスペリジン1質量部、デキストリン(DE10)4質量部、及び亜硫酸ナトリウム0.06質量部を順次添加し、30分間撹拌しつつ溶解し、0.01規定塩酸溶液にて中和した後、直ちにジオバチルス・ステアロサーモフィラス Tc-91株(独立行政法人製品評価技術基盤機構、特許生物寄託センター 受託番号FERM BP-11273)由来のCGTaseをデキストリングラム当り20単位加え、pH6.0、75℃に維持し、攪拌しつつ、24時間反応させた。得られた酵素反応液をサンプリングして、HPLCで分析したところ、ヘスペリジンの約69%が、α-グリコシルヘスペリジンに変換していた。次いで、得られた酵素反応液に還元剤としてピロ亜硫酸ナトリウムを0.03%となるように添加し、90℃で120分間加熱した後、グルコアミラーゼ(商品名『グルコチーム』、ナガセケムテックス社製)を当該中間生成物グラム当り50単位加え、pH5.0、55℃に維持しつつ10時間反応させ、α-グルコシルヘスペリジンを生成させた。得られた酵素反応液を加熱して残存する酵素を失活させ、濾過し、濾液を多孔性合成吸着剤、商品名『ダイヤイオンHP-10』(三菱化学株式会社販売)を充填したカラムにSV2で通液した。その結果、溶液中のα-グルコシルヘスペリジンと未反応ヘスペリジンとが多孔性合成吸着剤に吸着し、糖類や塩類などは吸着することなく流出した。次いで、カラムに精製水を通液し、カラムを洗浄した後、エタノール水溶液濃度を段階的に高めながら更に通液し、α-グルコシルヘスペリジン含有画分を採取し、減圧濃縮し、粉末化して、淡黄色の粉末状グリコシルヘスペレチンを固形物当り原料のヘスペリジン質量に対して約68%の収率で得た。なお、本例で得られた粉末状グリコシルヘスペレチンは、α-グルコシルヘスペリジン77.0%、ヘスペリジン15.5%、その他の成分を7.5%含有していた。
1規定水酸化ナトリウム水溶液4質量部を80℃に加温し、この温度を維持しつつ、これに還元剤として亜硫酸ナトリウム0.1質量部、ヘスペリジン1質量部、及びデキストリン(DE10)4質量部を順次添加し、30分間撹拌しつつ溶解し、これに0.01規定塩酸溶液を加えて中和した後、直ちにジオバチルス・ステアロサーモフィラス Tc-91株(独立行政法人製品評価技術基盤機構、特許生物寄託センター 受託番号FERM BP-11273)由来のCGTaseをデキストリングラム当り20単位加え、pH6.0、75℃に維持し、攪拌しつつ、24時間反応させたところ、ヘスペリジンの約72%がα-グリコシルヘスペリジンに変換していた。得られた酵素反応液を加熱して残存する酵素を失活させ、濾過し、濾液を多孔性合成吸着剤、商品名『ダイヤイオンHP-20』(三菱化学株式会社販売)を充填したカラムにSV2で通液した。その結果、溶液中のα-グリコシルヘスペリジンと未反応ヘスペリジンとが多孔性合成吸着剤に吸着し、D-グルコース、塩類などは吸着することなく流出した。次いで、カラムに精製水を通液し、カラムを洗浄した後、エタノール水溶液濃度を段階的に高めながら更に通液し、α-グリコシルヘスペリジン含有画分を採取し、減圧濃縮し、粉末化して、淡黄色の粉末状グリコシルヘスペレチンを、固形物当り、原料のヘスペリジン質量に対して約71%の収率で得た。なお、本例で得られた粉末状グリコシルヘスペレチンは、α-グリコシルヘスペリジン76.0%、ヘスペリジン18.5%、その他の成分を5.5%含有していた。
ヘスペリジン1質量部、デキストリン(DE8)10質量部、及び還元剤としてピロ亜硫酸ナトリウム0.05質量部を水50質量部に添加し、pH9.5、90℃で70分間加熱し、次いで、ジオバチルス・ステアロサーモフィラス Tc-91株(独立行政法人製品評価技術基盤機構、特許生物寄託センター 受託番号FERM BP-11273)由来のCGTaseをデキストリングラム当り30単位加え、pH8.2、65℃に維持し、攪拌しつつ、40時間保持しつつ、この酵素反応が終了する直前に、酵素反応液に還元剤としてピロ亜硫酸ナトリウムを0.05%となるように添加し、85℃で加熱し、酵素を失活させた後、グルコアミラーゼ(商品名『グルコチーム』、ナガセケムテックス社製)を酵素反応液固形物グラム当り100単位加え、pH5.0、55℃に維持しつつ5時間反応させ、α-グルコシルヘスペリジンを生成させた。得られた酵素反応液を加熱して残存する酵素を失活させた。次いで、得られた酵素反応液に、α-L-ラムノシダーゼとしてヘスペリジナーゼ(商品名『可溶性ヘスペリジナーゼ<タナベ>2号』、田辺製薬製)を0.5質量部を添加し、pH4に調整し、55℃で24時間反応させ、得られた酵素反応液にピロ亜硫酸ナトリウム0.01質量部を添加し、加熱して酵素を失活させた後、濾過し、濾液を多孔性合成吸着剤、商品名『ダイヤイオンHP-10』(三菱化学株式会社販売)を充填したカラムにSV2で通液した。その結果、溶液中のα-グルコシルヘスペリジン、7-O-β-グルコシルヘスペレチン、及び未反応ヘスペリジンとが多孔性合成吸着剤に吸着し、D-グルコース、塩類などは吸着することなく流出した。次いで、カラムに精製水を通液し、カラムを洗浄した後、エタノール水溶液濃度を段階的に高めながら更に通液し、α-グルコシルヘスペリジン含有画分を採取し、減圧濃縮し、粉末化して、淡黄色の粉末状グリコシルヘスペレチンを固形物当り原料のヘスペリジン質量に対して約70%の収率で得た。なお、本例で得られた粉末状グリコシルヘスペレチンは、α-グルコシルヘスペリジン81.9%、ヘスペリジン0.5%、7-O-β-グルコシルヘスペレチン8.9%、及びその他の成分を8.7%含有していた。
ヘスペリジン50質量部と還元剤として次亜硫酸ナトリウム1質量部とを0.25N水酸化ナトリウム水溶液90質量部に80℃で加熱溶解し、DE8のデキストリン150質量部を添加し溶解し、pH9.0に調整した後、ジオバチルス・ステアロサーモフィラス Tc-91株(独立行政法人製品評価技術基盤機構、特許生物寄託センター 受託番号FERM BP-11273)由来のCGTaseをデキストリン1質量部当たり15単位加え、60℃まで加温しながらpH8.3に調整し、6時間反応させた。その後、pH7.0に調整し、68℃に加温して40時間反応させた。酵素反応終了後、酵素を加熱失活させた後、濾過して酵素反応液を得た。酵素反応液をHPLCにより分析したところ、反応前液中のヘスペリジンの72%がα-グルコシルヘスペリジンに変換しており、残り28%は未反応のままであった。酵素反応液に、α-L-ラムノシダーゼとしてヘスペリジナーゼ(商品名『可溶性ヘスペリジナーゼ<タナベ>2号』、田辺製薬製)を2質量部を添加し、pH4に調整し、55℃で24時間反応させた後、グルコアミラーゼ(商品名『グルコチーム』、ナガセケムテックス社製)を1質量部加え、更に55℃で24時間反応させた。酵素反応終了後、得られた酵素反応液を加熱して酵素を加熱失活させ、中間極性多孔性吸着樹脂(商品名『アンバーライトXAD-7』、Rohm and Haas社製)を充填したカラムにかけ、カラムを水洗し、80v/v%エタノール水溶液にて樹脂吸着成分を溶出した。溶出液中のエタノールを除去した後、凍結乾燥し、α-グルコシルヘスペリジンを82.0%、7-O-β-グルコシルヘスペレチン8.0%、ヘスペリジンを1.0%、及びその他の成分を9.0%含む粉末状グリコシルヘスペレチンを得た。
酵素反応液に対し、還元剤としてのメタ亜硫酸カリウムを0.001%添加した以外は実施例1と同様にして、淡黄色の粉末状グリコシルヘスペレチンを固形物当り原料のヘスペリジン質量に対して約69%の収率で得た。なお、本例で得られた粉末状グリコシルヘスペレチンは、α-グルコシルヘスペリジン79.5%、ヘスペリジン13.8%、その他の成分を6.7%含有していた。
メタ亜硫酸カリウムを亜硫酸水素ナトリウムに代えた以外は実施例6と同様にして、淡黄色の粉末状グリコシルヘスペレチンを、乾燥固形物当り、原料のヘスペリジン質量に対して約65%の収率で得た。なお、本例で得られた粉末状グリコシルヘスペレチンは、α-グルコシルヘスペリジン77.2%、ヘスペリジン16.5%、その他の成分を6.3%含有していた。
後述する参考例1で得た粉末状グリコシルヘスペレチンに、その乾燥固形物当たり、亜硫酸ナトリウム、次亜硫酸ナトリウム、ピロ亜硫酸カリウム、又はピロ亜硫酸ナトリウムを0.03質量%添加し、均一に撹拌し、加熱し、精製し、粉末状グリコシルヘスペレチンを得た。
異性化液糖100質量部、砂糖2質量部、及び実施例1の方法で得た粉末状グリコシルヘスペレチン1質量部を80℃で30分間加熱処理してビタミンP強化液状混合甘味料を得た。
α,α-トレハロース(登録商標『トレハ』、株式会社林原販売)10質量部と水20質量部とを155℃の減圧下で、水分約2%以下になるまで濃縮し、次いで、120℃まで冷却し、これにクエン酸0.5質量部及び実施例2の方法で得た粉末状グリコシルヘスペレチン0.01質量部及びレモン香料を適量混和し、次いで常法に従って、成形、包装してビタミンP強化ハードキャンディーを得た。
酢酸カルシウム1水塩10質量部、L-乳酸マグネシウム3水塩50質量部、マルトース57質量部、実施例3の方法で得た粉末状グリコシルヘスペレチン20質量部及びエイコサペンタエン酸20%含有γ-シクロデキストリン包接化合物12質量部を均一に混合し、顆粒成形機にかけて顆粒とした後、常法に従って、ゼラチンカプセルに封入して、1カプセル当たり内容物を150mg含有するカプセル剤を得た。
DL-乳酸ナトリウム21質量部、ピルビン酸ナトウム8質量部、実施例4の方法で得た粉末状グリコシルヘスペレチン5質量、着色料、及び香料の適量と混合し、浴用剤を得た。
ポリオキシエチレンベヘニルエーテル0.5質量部、テトラオレイン酸ポリオキシエチレンソルビトール1質量部、親油型モノステアリン酸グリセリン1質量部、ピルビン酸0.5質量部、ベヘニルアルコール0.5質量部、アボガド油1質量部、実施例1の方法で得た粉末状グリコシルヘスペレチン1質量部、ビタミンE及び防腐剤の適量を、常法に従って加熱溶解し、これにL-乳酸ナトリウム1質量部、1,3-ブチレングリコール5質量部、カルボキシビニルポニマー0.1質量部、及び精製水85.3質量部を加え、ホモゲナイザーにかけ乳化し、更に香料の適量を加えて攪拌し、混合して乳液を製造した。
実施例4の方法で得た粉末状グリコシルヘスペリジン1質量部に対し、亜硫酸ナトリウム、次亜硫酸ナトリウム、ピロ亜硫酸カリウム、及びピロ亜硫酸ナトリウムから選ばれる1種又は2種以上を合計で0.0005質量部添加し、均一に混合して、健康補助飲食物としての15種類のビタミンP強化剤を得た。
実施例1乃至7で得た粉末状グリコシルヘスペレチンのいずれかを10質量部、蔗糖3質量部、マルチトール1質量部、及びデキストリン15質量部を撹拌混合し、スティック状の遮光・防湿性包装容器に5gずつ収容し、8種類の本発明の粉末状美容食品を得た。
実施例14で得た15種類のビタミンP強化剤のいずれかを2質量部、マルトース2質量部、精製水20質量部、及び適量のpH調製剤を混合撹拌し、pH7.2に調整し、精密濾過し、無菌容器に無菌的に充填し、15種類の本発明の液状美容食品を得た。
<粉末状グリコシルヘスペレチン>
従来の粉末状グリコシルヘスペレチンの製造方法として、実施例1の粉末状グリコシルヘスペレチンの製造方法において、還元剤としてピロ亜硫酸ナトリウムを用いない以外は、実施例1と同様にして、粉末状グリコシルヘスペレチンを得た。なお、本例で得られた粉末状グリコシルヘスペレチンは、α-グルコシルヘスペリジン77.0%、ヘスペリジン15.5%、その他の成分を7.5%含有していた。
Claims (24)
- フルフラールを実質的に含まず、乾燥固形物当たり、グリコシルヘスペレチンを90質量%以上100質量%未満含有することを特徴とするグリコシルヘスペレチン。
- GC/MS分析法で測定されたフルフラール含量が、乾燥固形物当たり、200ppb未満であることを特徴とする請求項1記載のグリコシルヘスペレチン。
- 4-メトキシスチレンを実質的に含まないことを特徴とする、請求項1又は2記載のグリコシルヘスペレチン。
- GC/MS分析法で測定された4-メトキシスチレン含量が、乾燥固形物当たり、30ppb未満であることを特徴とする、請求項1乃至3のいずれかに記載のグリコシルヘスペレチン。
- グリコシルヘスペレチンが、α-グリコシルヘスペリジンとともに、ヘスペリジン及び7-O-β-グルコシルヘスペレチンの一方又は双方を含むものであることを特徴とする、請求項1乃至4のいずれかに記載のグリコシルヘスペレチン。
- 乾燥固形物当たりのα-グリコシルヘスペリジンの含量が、50質量%以上100質量%未満であることを特徴とする、請求項1乃至5のいずれかに記載のグリコシルヘスペレチン。
- α-グリコシルヘスペリジンが、α-グルコシルヘスペリジンであることを特徴とする、請求項5又は6に記載のグリコシルヘスペレチン。
- 乾燥固形物当たり、α-グルコシルヘスペリジンを60乃至90質量%含有することを特徴とする、請求項7に記載のグリコシルヘスペレチン。
- 1w/w%水溶液とし、これを密閉容器中で100℃で30分間加熱した後、27℃に調整し、幅1cmのセルに入れ、分光光度計により波長420nm及び波長720nmにおける吸光度を測定したときの両波長における吸光度の差が0.24未満であることを特徴とする、請求項1乃至8のいずれかに記載のグリコシルヘスペレチン。
- 1w/w%水溶液とし、密閉容器中で100℃で30分間加熱した後、20℃としたときの電気伝導度が10μS/cm未満であることを特徴とする、請求項1乃至9のいずれかに記載のグリコシルヘスペレチン。
- 高周波誘導結合プラズマ発光分光分析法で測定したときの組成物の固形物当たりのカルシウム、カリウム、マグネシウム、及びナトリウムの含量がそれぞれ、1ppm以下、0.1ppm以下、0.2ppm以下、及び0.4ppm以下であることを特徴とする、請求項1乃至10のいずれかに記載のグリコシルヘスペレチン。
- 請求項1乃至11のいずれかに記載のグリコシルヘスペレチンを含んでなる、飲食品、嗜好品、化粧品、医薬品、医薬部外品、化学品、工業用原料及び資材、飼料、餌料、衣料、雑貨(日用品を含む)、又はプラスチック製品。
- (ア)ヘスペリジン及び澱粉部分分解物を含有する水溶液を調製する工程、(イ)得られた水溶液に糖転移酵素を作用させα-グルコシルヘスペリジンを含むグリコシルヘスペレチンを生成させる工程、及び(ウ)生成したグリコシルヘスペレチンを採取する工程、を含むグリコシルヘスペレチンの製造方法であって、前記(ア)乃至(ウ)の1又は2以上の工程を還元剤の存在下で実施するか、前記(ア)乃至(ウ)の1又は2以上の工程の前の始発原料及び/又は後の結果物に還元剤を添加することを特徴とする、請求項1乃至11のいずれかに記載のグリコシルヘスペレチンの製造方法。
- (イ)の工程で使用する糖転移酵素が、シクロマルトデキストリン・グルカノトランスフェラーゼ、α-グルコシダーゼ、及びα-アミラーゼから選ばれる1種又は2種以上であることを特徴とする、請求項13記載のグリコシルヘスペレチンの製造方法。
- (イ)の工程で得られた酵素反応液に、更にグルコアミラーゼ及び/又はα-L-ラムノシダーゼを作用させることを特徴とする、請求項13又は14記載のグリコシルヘスペレチンの製造方法。
- 還元剤が、無機系及び有機系の還元剤から選ばれる1種又は2種以上であることを特徴とする、請求項13乃至15のいずれかに記載のグリコシルヘスペレチンの製造方法。
- 無機系の還元剤が亜硫酸塩であることを特徴とする、請求項16に記載のグリコシルヘスペレチンの製造方法。
- グリコシルヘスペレチン含有物と還元剤とを接触させることを特徴とする、グリコシルヘスペレチン含有物の雑味低減方法。
- グリコシルヘスペレチンが、α-グリコシルヘスペリジンとともに、ヘスペリジン及び7-O-β-グルコシルヘスペレチンの一方又は双方を含むものであることを特徴とする、請求項19記載のグリコシルヘスペレチン含有物の雑味低減方法。
- α-グリコシルヘスペリジンが、α-グルコシルヘスペリジンであることを特徴とする、請求項18又は19に記載のグリコシルヘスペレチン含有物の雑味低減方法。
- α-グリコシルヘスペリジンの含量が、グリコシルヘスペレチン乾燥固形物当たり、50質量%以上100質量%未満であることを特徴とする、請求項18乃至20のいずれかに記載のグリコシルヘスペレチン含有物の雑味低減方法。
- 還元剤が、無機系及び有機系の還元剤から選ばれる1種又は2種以上であることを特徴とする、請求項18乃至21のいずれかに記載のグリコシルヘスペレチン含有物の雑味低減方法。
- 無機系の還元剤が亜硫酸塩であることを特徴とする、請求項18乃至22のいずれかに記載のグリコシルヘスペレチン含有物の雑味低減方法。
- 更に、グリコシルヘスペレチン含有物の着色も低減することを特徴とする、請求項18乃至23のいずれかに記載のグリコシルヘスペレチン含有物の雑味低減方法。
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020167026154A KR102172553B1 (ko) | 2014-03-03 | 2015-03-03 | 글리코실헤스페레틴과 그 제조방법 및 용도 |
JP2016506507A JP6675528B2 (ja) | 2014-03-03 | 2015-03-03 | グリコシルヘスペレチンとその製造方法並びに用途 |
CN201580011471.5A CN106661073B (zh) | 2014-03-03 | 2015-03-03 | 糖基橙皮素和其制造方法以及用途 |
US15/122,708 US10703773B2 (en) | 2014-03-03 | 2015-03-03 | Glycosyl hesperetin and process for producing the same and uses thereof |
BR112016020356-9A BR112016020356B1 (pt) | 2014-03-03 | 2015-03-03 | composição de glicosil hesperetina, produto alimentício, método para produzir uma composição de glicosil hesperetina e método para reduzir os sabores diversos de um produto compreendendo glicosil hesperetina |
ES15758551T ES2891177T3 (es) | 2014-03-03 | 2015-03-03 | Composición de glicosil hesperetina y procedimiento para producir la misma |
EP15758551.4A EP3135682B1 (en) | 2014-03-03 | 2015-03-03 | Glycosyl hesperetin composition and process for producing the same |
MX2016011424A MX2016011424A (es) | 2014-03-03 | 2015-03-03 | Glicosil hesperetina y procedimiento para la produccion de la misma y sus usos. |
EP21185566.3A EP3935960A1 (en) | 2014-03-03 | 2015-03-03 | Glycosyl hesperetin and process for producing the same and uses thereof |
PH12016501729A PH12016501729A1 (en) | 2014-03-03 | 2016-09-02 | Glycosyl hesperetin and process for producing the same and uses thereof |
US16/878,911 US11453694B2 (en) | 2014-03-03 | 2020-05-20 | Glycosyl hesperetin and process for producing the same and uses thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014-041066 | 2014-03-03 | ||
JP2014041066 | 2014-03-03 | ||
JP2014266504 | 2014-12-26 | ||
JP2014-266504 | 2014-12-26 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/122,708 A-371-Of-International US10703773B2 (en) | 2014-03-03 | 2015-03-03 | Glycosyl hesperetin and process for producing the same and uses thereof |
US16/878,911 Division US11453694B2 (en) | 2014-03-03 | 2020-05-20 | Glycosyl hesperetin and process for producing the same and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015133483A1 true WO2015133483A1 (ja) | 2015-09-11 |
Family
ID=54055289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2015/056230 WO2015133483A1 (ja) | 2014-03-03 | 2015-03-03 | グリコシルヘスペレチンとその製造方法並びに用途 |
Country Status (12)
Country | Link |
---|---|
US (2) | US10703773B2 (ja) |
EP (2) | EP3935960A1 (ja) |
JP (1) | JP6675528B2 (ja) |
KR (1) | KR102172553B1 (ja) |
CN (1) | CN106661073B (ja) |
BR (1) | BR112016020356B1 (ja) |
ES (1) | ES2891177T3 (ja) |
MX (1) | MX2016011424A (ja) |
MY (1) | MY177500A (ja) |
PH (1) | PH12016501729A1 (ja) |
TW (1) | TWI673282B (ja) |
WO (1) | WO2015133483A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020090137A1 (ja) * | 2018-10-30 | 2020-05-07 | 太陽化学株式会社 | 容器詰飲料 |
WO2020138026A1 (ja) | 2018-12-28 | 2020-07-02 | 株式会社林原 | 暑熱ストレス緩和剤 |
WO2022107735A1 (ja) | 2020-11-17 | 2022-05-27 | 株式会社林原 | 水晶体硬度調節剤 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6499740B2 (ja) * | 2016-10-13 | 2019-04-10 | フォーデイズ株式会社 | 食品組成物 |
CN109312375B (zh) * | 2018-04-25 | 2022-06-17 | 邦泰生物工程(深圳)有限公司 | 一种橙皮素的制备方法、橙皮素中间体的制备方法和用于制备橙皮素的生物酶 |
CN109652481A (zh) * | 2018-12-29 | 2019-04-19 | 浙江工业大学 | 一种环糊精糖基转移酶在生产α-糖基橙皮苷中的应用 |
CN116143745B (zh) * | 2023-04-04 | 2023-08-22 | 华南理工大学 | 一种从柑橘皮中一步提取制备高纯度高活性橙皮素的方法 |
CN116870066B (zh) * | 2023-08-08 | 2024-04-30 | 浙大城市学院 | 一种高效率制备衢枳壳总黄酮的方法及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH037593A (ja) * | 1989-06-03 | 1991-01-14 | Hayashibara Biochem Lab Inc | α―グリコシル ヘスペリジンとその製造方法並びに用途 |
JPH1070994A (ja) * | 1996-06-26 | 1998-03-17 | Hayashibara Biochem Lab Inc | 酵素処理ヘスペリジンおよびその製造方法ならびに酵素処理ヘスペリジンの使用方法 |
JPH10323196A (ja) * | 1997-03-24 | 1998-12-08 | Hayashibara Biochem Lab Inc | α−モノグルコシルヘスペリジン高含有物の製造方法 |
JPH11346792A (ja) * | 1999-04-08 | 1999-12-21 | Hayashibara Biochem Lab Inc | α―グリコシルヘスペリジンとその製造方法並びに用途 |
JP2007039349A (ja) * | 2005-08-01 | 2007-02-15 | Hayashibara Biochem Lab Inc | ヘスペレチン−7−β−マルトシド及びその製造方法並びにその用途 |
JP2011126849A (ja) * | 2009-12-21 | 2011-06-30 | Ito En Ltd | ヘスペリジン含有飲料 |
WO2013018779A1 (ja) * | 2011-08-01 | 2013-02-07 | 株式会社林原 | α-グルコシルヘスペリジンの結晶とその用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5663223A (en) * | 1994-08-11 | 1997-09-02 | Zapata Technologies, Inc. | Flavor protectant closure liner compositions |
WO1998042859A1 (en) * | 1997-03-24 | 1998-10-01 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | PROCESS FOR PRODUCING α-MONOGLUCOSYLHESPERIDIN-RICH SUBSTANCE |
JP3060227U (ja) | 1998-12-22 | 1999-08-17 | 株式会社日本標準 | 学習漢字一覧表 |
AR028394A1 (es) * | 2000-05-12 | 2003-05-07 | Coca Cola Co | Jugos de fruta que tienen un flavor y duracion de la conservacion de la calidad aumentadas |
WO2009096042A1 (ja) * | 2008-01-31 | 2009-08-06 | Kao Corporation | 味噌 |
KR102554508B1 (ko) | 2014-08-20 | 2023-07-13 | 가부시기가이샤하야시바라 | 경구 미용제 |
-
2015
- 2015-03-03 MY MYPI2016703089A patent/MY177500A/en unknown
- 2015-03-03 BR BR112016020356-9A patent/BR112016020356B1/pt active IP Right Grant
- 2015-03-03 ES ES15758551T patent/ES2891177T3/es active Active
- 2015-03-03 EP EP21185566.3A patent/EP3935960A1/en active Pending
- 2015-03-03 US US15/122,708 patent/US10703773B2/en active Active
- 2015-03-03 EP EP15758551.4A patent/EP3135682B1/en active Active
- 2015-03-03 MX MX2016011424A patent/MX2016011424A/es unknown
- 2015-03-03 JP JP2016506507A patent/JP6675528B2/ja active Active
- 2015-03-03 TW TW104106680A patent/TWI673282B/zh active
- 2015-03-03 KR KR1020167026154A patent/KR102172553B1/ko active IP Right Grant
- 2015-03-03 WO PCT/JP2015/056230 patent/WO2015133483A1/ja active Application Filing
- 2015-03-03 CN CN201580011471.5A patent/CN106661073B/zh active Active
-
2016
- 2016-09-02 PH PH12016501729A patent/PH12016501729A1/en unknown
-
2020
- 2020-05-20 US US16/878,911 patent/US11453694B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH037593A (ja) * | 1989-06-03 | 1991-01-14 | Hayashibara Biochem Lab Inc | α―グリコシル ヘスペリジンとその製造方法並びに用途 |
JPH1070994A (ja) * | 1996-06-26 | 1998-03-17 | Hayashibara Biochem Lab Inc | 酵素処理ヘスペリジンおよびその製造方法ならびに酵素処理ヘスペリジンの使用方法 |
JPH10323196A (ja) * | 1997-03-24 | 1998-12-08 | Hayashibara Biochem Lab Inc | α−モノグルコシルヘスペリジン高含有物の製造方法 |
JPH11346792A (ja) * | 1999-04-08 | 1999-12-21 | Hayashibara Biochem Lab Inc | α―グリコシルヘスペリジンとその製造方法並びに用途 |
JP2007039349A (ja) * | 2005-08-01 | 2007-02-15 | Hayashibara Biochem Lab Inc | ヘスペレチン−7−β−マルトシド及びその製造方法並びにその用途 |
JP2011126849A (ja) * | 2009-12-21 | 2011-06-30 | Ito En Ltd | ヘスペリジン含有飲料 |
WO2013018779A1 (ja) * | 2011-08-01 | 2013-02-07 | 株式会社林原 | α-グルコシルヘスペリジンの結晶とその用途 |
Non-Patent Citations (2)
Title |
---|
KOMETANI, T. ET AL.: "Synthesis of Neohesperidin Glycosides and Naringin Glycosides by Cyclodextrin Glucanotransferase from an Alkalophilic Bacillus Species", BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 60, no. 4, 1996, pages 645 - 649, XP055358037 * |
See also references of EP3135682A4 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020090137A1 (ja) * | 2018-10-30 | 2020-05-07 | 太陽化学株式会社 | 容器詰飲料 |
JPWO2020090137A1 (ja) * | 2018-10-30 | 2021-04-08 | 太陽化学株式会社 | 容器詰飲料 |
WO2020138026A1 (ja) | 2018-12-28 | 2020-07-02 | 株式会社林原 | 暑熱ストレス緩和剤 |
WO2022107735A1 (ja) | 2020-11-17 | 2022-05-27 | 株式会社林原 | 水晶体硬度調節剤 |
Also Published As
Publication number | Publication date |
---|---|
KR20160127763A (ko) | 2016-11-04 |
US10703773B2 (en) | 2020-07-07 |
BR112016020356B1 (pt) | 2020-12-08 |
US20170081354A1 (en) | 2017-03-23 |
EP3135682A1 (en) | 2017-03-01 |
US11453694B2 (en) | 2022-09-27 |
CN106661073A (zh) | 2017-05-10 |
EP3935960A1 (en) | 2022-01-12 |
EP3135682A4 (en) | 2017-08-16 |
ES2891177T3 (es) | 2022-01-26 |
CN106661073B (zh) | 2019-12-20 |
EP3135682B1 (en) | 2021-08-25 |
US20200283466A1 (en) | 2020-09-10 |
MX2016011424A (es) | 2016-12-02 |
KR102172553B1 (ko) | 2020-11-03 |
TW201623322A (zh) | 2016-07-01 |
TWI673282B (zh) | 2019-10-01 |
JPWO2015133483A1 (ja) | 2017-04-06 |
JP6675528B2 (ja) | 2020-04-01 |
PH12016501729A1 (en) | 2016-12-19 |
MY177500A (en) | 2020-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11453694B2 (en) | Glycosyl hesperetin and process for producing the same and uses thereof | |
JP7049496B2 (ja) | 黄ぐすみ低減用皮膚外用剤 | |
KR0158454B1 (ko) | 알파-글리코실 루틴의 제조방법 | |
JP2014043472A (ja) | エクオール類を有効成分とする美白剤 | |
US20110207697A1 (en) | Xanthohumol compositions and methods for treating skin diseases or disorders | |
JPWO2016056648A1 (ja) | 酸性水系媒体中での2−O−α−D−グルコシル−L−アスコルビン酸の安定化方法 | |
JP6678928B2 (ja) | 経口美容剤 | |
JP4051482B2 (ja) | α−グリコシルヘスペリジンを含んでなる医薬組成物 | |
KR102716629B1 (ko) | 황변 현상 저감용 피부외용제 | |
JP6969760B2 (ja) | 毛髪の成長を促進させる組成物 | |
JP7029825B2 (ja) | セラミド類含有組成物の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15758551 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2016506507 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15122708 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12016501729 Country of ref document: PH Ref document number: MX/A/2016/011424 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2015758551 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015758551 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20167026154 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: IDP00201606580 Country of ref document: ID |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112016020356 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112016020356 Country of ref document: BR Kind code of ref document: A2 Effective date: 20160902 |